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SUMMARY 
SUMMARY 
Uric acid (2,6,8-trioxo purine) is produced in mammalian systems as an end 
product of purine metabolism and has been proposed as a natural, physiological 
antioxidant. In the presence of Cu(II) and molecular oxygen, uric acid caused 
breakage of calf thymus DNA and supercoiled plasmid DNA. Such breakage 
was considerably enhanced in the presence of visible light. The DNA cleavage 
did not appear to have any preferred site(s) or sequence(s) for strand scission. 
Uric acid catalyzed the reduction of Cu(II) to Cu(I), which was shown to be 
an essential intermediate in the DNA cleavage reaction. Uric acid also 
reduced oxygen to superoxide and hydroxyl radicals were formed in the 
presence of Cu(II). The involvement of active oxygen species in the reaction 
was established by the inhibition of DNA breakage by known scavengers of 
oxygen radicals. Flourescence quenching experiments indicated that uric acid 
is capable of binding to DNA. 
Experiments were also done to study the viability of bacteriophage lambda on 
reaction with uric acid and Cu(II). hicreasing concentrations of uric acid and 
Cu(II) resulted in a progressive loss of survival of the phage. The effect of U V-
irradiation of host cells on the uric acid-Cu(II) mediated sensitivity of phage 
was also studied. There was some evidence that the treatment enhanced the 
recovery of phage, indicating the involvement of U V-inducible pathway in the 
repair of uric acid-Cu(II) mediated DNA damage. Using various repair 
defective mutants of E. coli it was shown that DNA repair occurs and 
predominantly involves the polk pathway. The uric acid induced mutation 
spectrum in the /acZa gene of plasmid Bluescript SK +/- was characterized 
by broadly distributed single base substitutions and deletions. In addition, the 
frequency of G-^C transversions was relatively greater than C->G 
transversions. The number of transition mutations however, was quit low. 
INTRODUCTION 
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Oxygen radicals and human disease 
It is well established that aerobic organisms produce reactive oxygen species 
during the course of normal metabolism. These include superoxide anion, 
hydrogen peroxide and the hydroxyl radical (Fridovich^, 1989; Sies, 1991; 
Weiss, 1989). Oxidative DNA damage by these species has been implicated 
in a number of human diseases, including cancer. The other diseases where 
such damage may play an important role are rheumatoid arthritis (Gridley, et 
al, 1993), Alzheimer's disease, Parkinson's disease and amyotrophic lateral 
sclerosis (ALS) (Sanches-Ramos and Ames, 1994; Mecocci et al, 1994; 
Robberecht et al, 1994). In this last disease it has been suggested that a lack 
of superoxide dismutase (SOD) activity or a mutant form of this enzyme may 
be an important factor (Spencer et al, 1994). In addition, oxygen radical 
toxicity is considered to be the cause of human male infertility (Aitken and 
Fisher, 1994). 
One of the theories of etiology of cancer, wdiich is widely accepted, holds that 
the major cause is damage to DNA by oxygen radicals and lipid peroxidation 
(Ames, 1983; Totter, 1980). Several enzymes produce superoxide (O-'') 
during the oxidation of their substrates, for example, xanthine oxidase and 
peroxidase (Buettner et al, 1978; Duran et al, 1977). Numerous substances 
such as reduced flavins and ascorbic acid upon autoxidation produce 
superoxide anion. This radical further accepts an electron from a reducing 
agent, such as thiols, to yield peroxide (H^O^). There is in vitro evidence that 
H^O^ may then react with certain chelates of copper and iron to yield the 
highly reactive hydroxyl radical (OH') (Wolff ef al., 1986). That the superoxide 
anion actually appears in metabolism is confirmed by the ubiquitous occurance 
of superoxide dismutase. Indeed, certain white blood cells generate superoxide 
deliberately by means of a specialized membrane bound NADPH-oxidase 
and this participates in the killing of microorganisms and tumor cells (Wolff 
etal., 1986). 
It has been suggested that certain promoters of carcinogenesis act by 
generation of oxygen radicals, this being a common property of these 
substances. Fat and hydrogen peroxide are among the most potent promotors 
(WelschandAylsworth, 1983). Other well known cancer promoters are lead, 
calcium, phorbol esters, asbestos and various quinones. Inflammatory reactions 
lead to the production of oxygen radicals by phagocytes and this is the basis 
of cancer promotion by asbestos (Hatch et al., 1980). Many carcinogens 
which do not require the action of promotors and are by themsleves able to 
induce carcinogenesis (complete carcinogens), also produce oxygen radicals 
(Demopoulose? a/., 1980). These include nitoroso compounds, hydrazines, 
quinones and polycyclic hydrocarbons. Much of the toxic affect of ionizing 
radiation damage to DNA is also due to the formation of oxygen radicals 
(Totter, 1980). The mechanism of action of promotors involve the expression 
of recessive genes and an increase in the gene copy number through 
chromosome breaks and creation of hemizygosity(Kinsella, 1982; Varshavsky, 
1981). Promotors also cause modification of prostaglandins which are 
intimately involved in cell division, differentiation and tumor growth (Fischer 
et al., 1982). Most data on radical damage to biological macromolecules 
concerns with the effects of radiation on nucleic acids because of the possible 
genetic affects. However, in view of the catalytic role of enzymes, damage 
to proteins is also considered important. It has been suggested that primary 
oxygen radicals, produced in cells, and their secondary lipid intermediates 
modify and fragment proteins. The products are often more susceptible to 
enzymetic hydrolysis leading to accelerated proteolysis inside and outside the 
cells (Wolffef a/., 1986). 
Anticarcinogens and antioxidants 
The protective defence mechanisms against mutagens and carcinogens 
include the shedding of surface layer of the skin, cornea and the alimentary 
canal. If oxygen radicals play a major role in DNA damage, defence against 
these agents is obviously of great importance (Totter, 1980). The major source 
of endogenous oxygen radicals are hydrogen peroxide and superoxides 
which are generated as side products of metabolism (Pryor, 1976 -
1982). In addition, oxygen radicals also arise from phagocytosis after viral and 
bacterial infection or in inflammatory reactions (Tauber, 1982). The 
exogenous oxygen radical load is contributed by a variety of environmental 
agents (Pryor, 1976 - 1982). The enzymes that protect cells from oxidative 
damage are superoxide dismutase, glutathione peroxidase (Pryor, 1976 -
1982), D.T. diaphorase (Lind et al., 1982) and glutathione transferases 
(Warholm et al., 1981). In addition to these enzymes, some small molecules 
in the human diet act as antioxidative agents and presumably have an 
anticarcinogenic effect. Some of these compounds are discussed below. 
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a-Tocopherol (Vitamin E) is an important trap of oxygen radicals in membrane 
(Pryor, 1976 - 1982) and has been shown to decrease the carcinogenic effect 
of quinones, adriamycin and daunomycin, which are toxic because of free 
radical generation (Ames, 1983). Protective effects of tocopherol against 
radiation induced DNA damage and dimethyl hydrazine induced 
carcinogenesis have also been observed (Beckman et al., 1982). 6-carotene 
is a potent antioxidant present in the diet and is important in protecting lipid 
membrane against oxidation. Singlet oxygen ('O2) is a highly reactive form 
of oxygen which is mutagenic and is mainly generated by pigment mediated 
transfer of energy of light to oxygen. Carotenoids are free radical traps and are 
remarkably efficient as quenchers of singlet oxygen (Packer et al., 1981). 6-
carotene and similar polyprenes are also the main defence in plants against 
singlet oxygen generated as a by-product of the interaction of light and 
chlorophyll (Krinsky and Deneke, 1982). Carotenoids have been shown to 
be anti-carcinogenic in rats and mice and may also have a similar afifect in 
humans (Mathews-Roth, 1982; Peto et al., 1981). Glutathione is present in 
food as one of the major antioxidant and is antimutagenic in cells. Glutathione 
transferases are a major defence against oxidative and alkylating carcinogens 
(Warholm et al., 1981). Dietary glutathione is an effective anticarcinogen 
against aflatoxins (Novi, 1981). The cellular concentration of glutathione is 
influenced by dietary sulphur amino acids (Tateishi et al., 1981). Selenium, 
which is present in the active site of glutathione peroxidase, is another 
important dietary anticarcinogen. Glutathione peroxidase is essential for 
destroying lipid hydro-peroxides and endogenous hydrogen peroxide and 
therefore helps to prevent oxygen radical induced lipid peroxidation (Flohe, 
1982). Several heavy metal toxins, such as Cd^ "^  (a knovvTi carcinogen) and 
Hg^ ^ decrease glutathione peroxidase activity by interaction with selenium 
(Flohe, 1982). Some other dietary antioxidants include, ascorbic acid and uric 
acid. The former has been shown to be anti-carcinogenic in rodents treated 
with light and benzo(a)pyrene (Hartman, 1982). Uric acid is present in high 
concentrations in the blood of humans and is a strong antioxidant (Ames^ et 
al. 1981). A low uric acid level has been considered a risk factor in cigarette 
caused lung cancer, however, too high levels may cause gout. 
In addition, edible plants contain a variety of substances such as phenols that 
have been reported to inhibit or enhance carcinogenesis and mutagenesis in 
experimental animals (Ames, 1983). The inhibitory action of such compounds 
may be due to the induction of cytochrome P-450 and other metabolic 
enzymes (Boyd era/., 1982). The optimum levels ofdietary antioxidants have 
not been determined; however, there might be a considerable variation among 
individuals. On the other hand, high doses of such compounds may lead to 
deleterious side eflfects. The difference in cancer rates of various populations 
are generally considered to be due to environmental and life style factors such 
as smoking, dietary carcinogens and promotors. However, these differences 
may also be due, in good part, to insufficient amounts of anticarcinogens and 
other protective factors in the diet (Maugh, 1979). 
In the past two decades, there has been much emphasis on the induction of 
cancer by occupational and industrial pollution factors. There is growing 
recognition, however, that these may account for a small fraction of human 
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cancers. It is becoming increasingly clear from epidemiological and 
laboratory data that diet is an important factor in the etiology of certain human 
cancers. It has been suggested by Doll and Peto (1981) that in the United 
States diet accounts for 35% of cancer deaths. According to these authors, 
there are five possible ways whereby diet may affect the incidence of cancer 
: (i) ingestion of powerful, direct acting carcinogens or their precursors, (ii) 
affecting the formation of carcinogens in the body, (iii) affecting transport, 
activation or inactivation of carcinogens, (iv) affecting 'promotion' of cells 
that are already initiated, and (v) ovemutrition. Normal individual 
consumption of potentially mutagenic substances per day from foods and 
beverages is estimated to be between 1 to 2 grams. In addition, the 
endogenous conditions favour the formation of still more mutagens in vitro 
in humans (Oshshima and Bartsch, 1981). 
The antioxidants of human extracellular fluids 
An antioxidant is defined as any substance that, when present at low 
concentrations compared to those of an oxidizable substrate, significantly 
delays or inhibits oxidation of that substrate. (Halliwell and Gutteridge, 1989). 
Antoxidants can act by: (i) decreasing localized oxygen (O.) concentrations 
(by combining with or displacing 0-), (ii) scavenging hydroxyl radicals 
(OH*) capable of abstracting hydrogen atoms and quenching or scavenging 
singlet oxygen ( O.) which can react with lipids to produce peroxides (Di 
Mascio et al., 1989), (iii) binding metal ions in forms that will not generate 
reactive species (like OH", ferryl or Fe^ /^Fe^VO complexes), (iv) removing 
-n 
peroxides by converting them into non-radical products, like alcohols and (v) 
reacting with chain propagating radicals (peroxyl or alkoxyl), preventing 
continued hydrogen abstraction from fatty acid side chains. 
Majorprimary intracellular antioxidants are the enzymes superoxide dismutase, 
catalase and glutathione peroxidase (Ursini and Bindoli, 1987; Touati, 1989; 
Fridovich^ 1989; Sies, 1985; Beyr and Fridovich, 1988; Halliwell and 
Gutteridge, 1989). The extracellular fluids of human body, such as blood, 
seminal plasma, tissue, cerebrospinal and synovial fluid, contain little or no 
catalase activity and only low activities of superoxide dismutase and selenium 
containing glutathione peroxidase (Thomson, 1985; Blake et al., 1981). The 
last has been purified from human plasma and shown to be functionally 
different from the intracellular enzyme (Avissar et al., 1989; Maddipati and 
Mamett, 1987; Takahashi etal, 1987). Reduced glutathione originates from 
liver (Meister, 1988) and very little of it is present (2.0 ^M) in human plasma 
(Svardal e? fl/., 1990). 
Extracellular superoxide dismutase (SOD, purified by Marklund and Karlsson 
(Karlsson and Marklund^ 1988; Marklund, 1984; Karlsson and Marklund^, 
1988), contains copper and zinc but they are very different from intracellular 
copper and zinc superoxide dismutase (Murklund, 1984). Although biological 
role of extracellular superoxide dismutase is unclear (Halliwell and Gutteridge, 
1989; Blake et al., 1981), it binds to heparin and in vivo may be associated 
with endothelial cell surfaces as a protective antioxidant over the cells 
(Karlsson and Marklund^*^ 1988). Removal of O *^" and H^O^ by SOD, 
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catalase or glutathione peroxidase contributes little to the antioxidant activity 
of extracellular fluids (Halliwell and Gutteridge, 1986). Plasma lipoproteins 
contain a-tocopherol as a major chain breaking antioxidant (Ingold et al., 
1987; Esterbauer et al., 1989). It has been argued by various authors that the 
major antioxidant defence of human plasma involves binding of transition 
metal ions in forms that will not stimulate free radical reactions, or to 
otherwise prevent the metal ions from participating in such reactions 
(Gutteridge^ 1982; Halliwell, 1981; Halliwell and Gutteridge, 1986; Gutteridge 
and Halliwell, 1988; Stocks et al, 1974). 
Transferrin present in plasma is loaded with iron and the protein lactoferrin, 
present in human secretions, also released by neutrophils, can act as an 
antioxidant by binding iron ions (Gutteridge et al., 1981; Aruoma and 
Halliwell, 1987; Kvizenga et al, 1987; Britigan et al, 1986). Because 
hemoglobin can be liberated into plasma and other body fluids after tissue 
injury, plasma contains hemoglobin binding proteins, haptoglobins, as well as 
heme-binding protein, hemopexin. Binding ofhemoglobin to haptoglobins or 
of heme to hemopexin diminishes the affectiveness of these iron compounds 
to stimulate oxidative damage. The plasma copper containing protein, 
ceruloplasmin, plays an essential role in iron metabolism, but it also has 
antioxidant properties (Stocks et al 1974; Gutteridge and Stocks, 1981). 
Ceruloplasmin also binds copper ions non-specifically and can thus inhibit 
copper ion-stimulated formation of reactive oxidants (e.g. OH") (Gutteridge 
etal, 1984; Lovstad, 1987). Thus hemopexin, haptoglobins and ceruloplasmm 
are important additional defences against oxidative damage in the body 
-13 
Albumin can also bind copper ions, and it usually inhibits copper ion-
dependant lipid peroxidation and OH' radical formation (Gutteridge and 
Wilkins, 1983; Halliwell, 1988; Rowley and Halliwell, 1983). Active oxygen 
production often continues at the site of metal ion binding and damages the 
protein (Marx and Chevion, 1986), but because of high concentration and 
rapid turnover of albumin in plasma the damage is probably biologically 
redundant (Halliwell, 1988). Ascorbic acid, present in plasma, has multiple 
antioxidant properties (Halliwell and Gutteridge, 1990) including an ability to 
regenerate a-tocopherol by reducing a-tocopheryl radicals at membrane 
surfaces. Mixtures of ascorbic acid and iron or copper ions have powerful 
prooxidant properties (Minotti and Aust, 1987; Aruoma et al., 1989; Ursini 
et al., 1989; Halliwell and Gutteridge, 1985), emphasizing the need for 
careftil sequesteration of free transition metal ions in plasma in order for 
ascorbic acid to exert its antioxidant action. 
From the forgoing it would appear that whereas the intracellular antioxidant 
mechanisms primarily involve radical removing enzymes, the extracellular 
antioxidant systems are dependant on the presence of antioxidant compounds 
and proteins in various fluids. Table!, partially summarizes the mode of action 
of some major antioxidants present in human body fluids. 
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T A B L E I : ANTIOXroANTS O F H U M A N B O D Y F L U I D S (Halliwell and Guttendge, 1990) 
Antioxidant Mode of action Comments 
Heptoglobin/Hemopexin 
Transferrin 
Uric acid 
a-tocopherol 
Glucose 
Bilirubin 
Albumin 
Ceruloplasmin 
Binds free hemoglobin/heme. 
Hemoglobin and methemoglobin 
release iron readily on exposure 
to HjOj or peroxides and can 
accelerate lipid peroxidation; 
binding to heptoglobin/hemopexin 
hinders this. 
Binds iron ions and prevents them 
from accelerating free radical 
reactions. 
Inhibits lipid peroxidation. 
Acute phase proteins 
Lipid soluble antioxidant; breaks 
chain by trapping peroxyl and 
alkoxyl radicals 
Scavenger of OHradicals, rate 
constant comparable to that of 
mannitol. 
Bile pigment produced by heme 
catabolism. May protect albu-
min bound fatty acids from 
peroxidation. 
Binds free Cu^^ ions and site 
directs any radical damage on 
to albumin molecule itself. Trans-
ports bilirubin. Scavenger of 
HOCl. 
Inhibits iron stimulated OH gene-
ration,also lipid peroxidation 
stimulated by iron or copper ions, 
Reacts slowdy with Ct^ and H^O, 
Ferroxidase activity does not 
result in formation of damaging 
oxygen radicals,unlike the none-
enzymetic oxidation ofFe-^^, 
which gives OH' and other 
powerful oxidants. 
Lactoferrin acts similarly 
Ability to bmd iron and copper 
ions tightly is an important 
part of its antioxidative role, as 
is direct scavenging of peroxyl, 
alkoxyl radicals and HOCl. 
Most important plasma antioxi 
dant. Protects plasma lipoproteins 
against oxidation 
Normal plasma concentration 
4.5 mM. Direct OH" scavengmg 
of little physiological signifi-
cance in vivo. 
It is also sensitizer of single O, 
production. 
Oxidant damaged albumin can 
be rapidly removed from 
arculation and degraded 
Acute phase protein 
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FIGURE 1 : STRUCTURE OF URIC ACID 
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SCOPE OF THE WORK PRESENTED 
Uric acid [7,9-Dihydro-l H-Purine-2,6,8(3H)tri-one] is a 2,6,8-tri-oxo purine 
(Figure 1) produced in the mammalian system as an end product of purine 
metabolism (Figure 2) (David et ai, 1985) and may function as an antioxidant 
in vivo {AmQs^et al., 1981; Cutler, 1984 Peden et ai, 1990). Uric acid also 
forms the end product of nitrogen metabolism of birds and scaley reptiles 
(Bahl and Bahl, 1977). Uric acid is so named as it was first discovered and 
isolated by Scheel and Bergmann (1776) from human urine. Bishop and 
Talbott (1953) first reported the role of uric acid in the biological processes. 
Uric acid is a white, odourless, tasteless, crystalline metabolite that decomposes 
without melting and with evolution of hydrogen cyanide (Merck Index, 1983). 
It behaves as a tribasic acid due to enolization. With sodium carbonate it gives 
acid salt and with sodium hydroxide normal salt is produced. The UV-
absorption spectrum of uric acid exhibits a characteristic absorption maximum 
at 290 nm. 
Traces of uric acid are found in the blood and small quantities are excreted in 
the urine. Owing to its small solubility any temporary excess of uric acid in 
the blood is deposited in joints (Gout) or tissues (Rheumatism) (Bahl and 
Bahl, 1977). Gout is a genetic or acquired disorder of uric acid metabohsm 
that leads to hyperuricemia and consequent acute and chronic arthritis. The 
recurrent but transient attacks of acute arthritis are triggered by precipitation 
into the joints, of monosodium urate crystals fi^om super saturated body 
fluids. Abnormal serum uric acid concentrations are encountered regularly in 
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FIGURE 2 : PATHWAY FOR THE GENERATION OF URIC 
ACID IN THE MAMMALIAN SYSTEM 
H0H2C-
C C 
I 1 
HO OH 
Adenosine 
Adenosine 
deaminose 
HOH2C-
C C 
H^ OH 
Inosine 
Ribose 
0 
P' —»v Purine nuc' 
l - P « > phosphor 
teoside 
ylQse 
0 
H 
>X Xanthine N 
idose 
HOH2C-C 
C~C 
H 6 (!>H 
Guonosine 
Purine nucleoside L -P ' 
PhosphorylQse k^Rlbose l -P 
Hypoxanthine 
Uric acid 
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such pathophysiological problems as hypertension, coronary artery disease, 
obesity, hyperlipidemia, diabetes maliitus, polycythemia and toximia of 
pregnancy (Frohlich, 1993). The normal uric acid pool in plasma of humans 
is 0.18 - 0.54 mM but the levels of uric acid and urate vary widely from 
individual to individual (0.05 - 0.9 mM), and, on average are some what higher 
in males than in females (0.37 vs. 0.26 mM in Bavaria) (Becker, 1993 and 
Gresser and Gathof, 1991). Wyngaarden in 1976 reported that the concentration 
of uric acid in blood is 5.0 mg/100 ml. In gouty people miscible or metabolic 
pool of uric acid is increased 2-4 times the normal (Boyd, 1961; Cotran et 
at., 1992). 
Antioxidant role of uric acid 
A marked increase in life span has occured in human evolution over the past 
60 million years (Cutler, 1976). At the same time an enormous decrease in 
the age specific cancer rates has occured in humans as compared to short lived 
animals (Peto, 1978; Dix and Cohen, 1980). It is considered that the major 
factor in the lengthening life-span and decreasing age specific cancer rates 
may be due to the evolution of effective protective mechanisms against 
oxygen radicals (Oberley et al., 1980; Ames^ et ah, 1981, Harman, 1980; 
Sohal, 1981; Halliwell, 1981). One such mechanism could be a high level of 
plasma uric acid (Ames* '^' et al., 1981). Uric acid is a powerful antioxidant 
and is a scavenger of singlet oxygen (Simon and Van, 1964) and radicals. 
Urate is much more easily oxidized then deoxynucleosides by singlet oxygen 
and is destroyed by hydroxyl radicals at a comparable rate. Urate is oxidized 
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by hydrogen peroxide in the presence of hematin or methemoglobin (Howell 
and Wyngaarden, 1960). It is presumably protective not only to erythrocytes, 
but also to DNA containing longer lived T and B lymphocytes and macrophages. 
Urate level in blood increases with excercise and lead exposure. High alcohol 
ingestion and obesity etc. are all associated with increased urate levels in man 
(Emmerson, 1978). Role of urate in brain remains to be evaluated, but 
connections between plasma urate levels, as well as a connection between 
RNA ingestion (which increases urate levels) and memory have been 
postulated (Park et al., 1980; Glassman, 1969). 
Urate and ascorbate differ in their protective abilities depending on the 
particular biological system involved. Both react with hydroxyl radicals and 
can protect the enzyme lactate dehydrogenase (LDH) from free radical 
mediated damage (Aruoma and Halliwell, 1989). However, with yeast 
alcohol dehydrogenase (YADH) and liver alcohol dehydrogenase (LADH), 
the presence of uric acid markedly enhances the damage induced. The extent 
of inactivation is considerably reduced in the absence of oxygen (Kittndge 
and Wilson, 1984). Uric acid is capable of inhibiting oxygen free radical-
induced DNA damage (Cohen e? a/., 1984). Metabohsm of acetaldehyde by 
xanthine oxidase leads to the production of superoxide anion (Hodgson and 
Fridovich, 1976; Brown and Fridovich, 1981). Although neither component 
alone is effective, the action of xanthine oxidase (an enzyme in uric acid 
catabolism) (Stryer, 1988) on acetaldehyde, in the presence of FeCl -ATP, 
leads to demonstrable DNA damage. But this superoxide mediated damage 
to DNA was inhibited by uric acid (-0.5 mM) concentration, approximately 
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that of human plasma (Akizuki, 1982). Uric acid is devoid of protective 
activity in Fe(Il)-nucleotide-H202 complex mediated damage to DNA, while 
hematin and cumene hydroperoxide mediated damage to DNA is inhibited by 
uric acid (Cohen et al., 1984). Uric acid can inhibit oxidative reactions without 
itself being oxidized (Davies et al.^ 1986). It also inhibits oxidation of 
ascorbic acid in blood by forming stable urate-transition metal ion complexes 
(Albert, 1953), although no urate oxidation results from this protection 
(Sevanian, et al., 1985). Urate forms stable complexes with ferric ions and is 
proposed to function as a low molecular weight iron binding agent in humans 
(Lovstad, 1992). Formation ofurate-Cu(n) complexes have also been reported 
(Lam et al., 1984). Oxygen containing free radicals have been implicated as 
causative agents in ageing, mutation, cancer and heart disease (Pryor, 1981). 
Indeed, measurement of oxidation products of uric acid may be a marker of 
oxidant generation in vivo (Grootveld and Halliwell, 1987; Halliwell et al., 
1988). The one electron uric acid oxidation product has not been detected and 
chemistry of actual free radical scavenging reaction has received little 
attention (Paul and Avi-Dor, 1954; Bentley and Neuberger 1952; Howell and 
Wyngaarden, 1960). Maples and Mason (1988) detected urate free radical, 
and by N ^  ^  isotopic labelling showed that the unpaired electron of urate anion 
free radical is located on the five membered ring of the purine structure and 
that such radical formation reaction may occur in vivo in mammalian systems. 
Uric acid protects DNA against oxidative damage (Cohen et al., 1984), 
inhibits ozone induced degradation of nucleic acid bases (Meadows and 
Smith, \ 986) and binds iron and copper ion in complexes (Davies e/ a/., 1986; 
Rowley and Halliwell, 1985). Inactivation of a,-antiproteinase can acerbate 
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tissue damage including rheumatoid arthritis and emphysema (Kamboh, 
1985; Travis and Salvesen, 1983; Weiss, 1986; Carp and Janoff, 1980). Uric 
acid did not protect a.-antiproteinase against inactivation by hydroxy 1 or by 
superoxide/iron/ H-O. system (Aruoma and Halliwell, 1989) but enhanced 
the inactivation. Uric acid derived radical could be reduced back to uric acid 
in a 'repair' action (Arouma and Halliwell, 1989). Uric acid in body appears 
to break down at an increased rate when oxidants are generated (Grootveld 
and Halliwell, 1987; Halliwell etal., 1988). Increased concentrations of uric 
acid breakdown products observed in body fluids under diseased conditions 
suggest that uric acid reacts with some oxidants in vivo (Grootveld and 
Halliwell, 1987). However, reaction of uric acid with certain oxidizing 
species, such as OH' or peroxy radicals, can generate uric acid radicals that 
are themselves capable of biological damage (Kittridge and Wilson, 1984; 
Aruoma and Halliwell, 1989). 
Certain antioxidants, such as naturally occurring flavonoids, function as 
scavengers of reactive oxygen species like singlet oxygen (Takahama, 1984), 
superoxide anion (Takahama, 1983) and H.O, (Takahama et al., 1984). 
Previous and on-going studies in this laboratory on flavonoids have shown 
that flavonoids cause strand scission in DNA in vitro in the presence of Cu(Il) 
and molecular oxygen (Rahman et al., 1989). Such DNA damage is caused 
by the generation of active oxygen species such as OH* radical, superoxide 
ion and ^J^i ^^ ^^^ flavonoid-Cu(II) complex. Similarly, ascorbic acid, the 
antioxidant present in biological fluids generates active oxygen species in the 
presence of Cu(II) (Marx and Chevion^•'^^ 1986). 
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As discussed above, uric acid is a proposed, natural, physiological antioxidant 
and is classically a radical scavenger (Halliwell and Gutteridge, 1990). 
Reaction between uric acid and free radicals generates tautomeric urate 
radical anion with the unpaired electron shared between N 7 and N 9 (Maples 
and Mason, 1988) and this radical is considered to have the damaging effects 
on macromolecules (Willson et ah, 1985). It was therefore of interest to 
explore the action of uric acid on DNA in the presence of a transition metal 
ion, such as Cu(II). The experiments described in this thesis show that uric 
acid in the presence of Cu(II) interacts with DNA in vitro to cause strand 
breakage and that such breaks result from the generation of active oxygen 
species. It is also shown that uric acid-Cu(II) system is capable of inactivating 
bacteriophage lambda and generating mutations in plasmid DNA. 
EXPERIMENTAL 
-24 -
MATERIALS 
Chemicals used for the present studies were obtained from the following 
sources: 
C h e m i c a l s 
Acrylamide 
Agar-agar 
Agarose 
Ammonium persulphate 
Ampicillin 
BamHl 
Bathocuproine 
Bis-acrylamide 
Bovine pancreatic RNase 
Bovine serum albumin 
5-Bromo-4-chloro-3-indolyl-
6-D-Galactopyranoside 
(X-gal) 
Catalase 
Deoxyribonucleic acid 
(Calf thymus type I) 
S o u r c e s 
Sigma Chemical Co., USA 
Hi-Media, India 
Koch Light Laboratories, England 
Sigma Chemical Co., USA 
Ranbaxy, India 
New England Biolabs, England 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Dimethyldichloro silane Fluka, Switzerland 
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Diphenylamine 
EcoR] 
HindlU 
Histidine 
Ethidium bromide 
Ethylene-diamine tetra 
acetic acid 
Isopropyl-6-D-thiogalacto-
pyranoside (IPTG) 
Luria broth 
Ml3 sequencing primer 
Mannitol 
Neocuproine hydrochloride 
Nitroblue tetrazolium 
Nutrient broth 
pBluescript SK+/- DNA 
p-nitrosodimethyl aniline 
Potassium iodide 
Pstl 
Riboflavin 
S, nuclease 
BDH, India 
New England Biolabs, England 
New England Biolabs, England 
E. Merck, Germany 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
Hi-Media, India 
Genei, India 
E. Merck, Germany 
Sigma Chemical Co., USA 
Sisco Research Labs., USA 
Hi-Media, India 
Gift from Dr. J.H. Parish 
Dept. of Biochem. & Mol. Biol. 
University of Leeds, Leeds, UK 
Aldrich Chemical Co. USA 
E. Merck, Germany 
New England Biolabs, England 
Sigma Chemical Co., USA 
Pharmacia Biotech. LKB, Sweden 
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Sodium azide 
Sodium benzoate 
Streptomycin 
Supercoiled pBR322 DNA 
Superoxide dismutase 
Tetracyclin 
Tris (Hydroxymethyl)-
amino methane 
Triton X-100 
N,N ,N' ,N' -tetramethyl-
ethylenediamin (TEMED) 
Urea 
Uric acid 
[a^^P] dATP 
E. Merck, Germany 
E. Merck, Germany 
IDPL, India 
Isolated and purified in the lab 
according to the procedure of 
Sambrooke^a/.,(1989) 
Sigma Chemical Co., USA 
Ranbaxy, India 
Fluka, Switzerland 
BDH, India 
Sigma Chemical Co., USA 
Qualigens, India 
Sigma Chemical Co., USA 
Bhaba Atomic Research Centre, 
Bombay, India 
All other chemicals were of analytical grade. 
Media for E, coli K-12 strains 
Nutrient broth (13.0 gm/1) obtained from Hi-Media (India) had the 
following concentration: 
Peptone 
NaCl 
Beef extract 
Yeast extract 
pH (approx.) 
5.0 gm/1 
5.0 gm/1 
1.5 gm/1 
1.5 gm/1 
7.4 + 0.2 
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Nutrient agar (Hard agar): 
Nutrient broth 
Agar powder 
Soft agar/Top agar: 
Nutrient broth 
Agar powder 
13.0 gm/1 
15.0 gm/1 
13.0 gm/1 
7.0 gm/1 
Bacterial Strains 
Strain Genetic markers 
designation 
Source 
AB1157 F", thr-1, ara-14, leuB6, A 
(gpt-proA) 62, lacYl, tsx-
33, qsr'", supE44, galK2, X~ 
, rac', his G4(0Q), rfbDl,mgl-
51,rpsL31, kdgK51,xyl-5,mtl-
l,argE3(0c), thi-1 
Barbara. J. Bachamnn 
E. coli Genetic Stock 
Centre, Department of 
Biology, 3550ML. Yale 
University, Post Box # 
6666, New Haven, CT, 
USA 
AB1886 F-,thr-l, ara-14, leuB6, 
A(gpt-proA)62, lacYl, tsx-
33, supE44,galK2, k, rac" his 
G4,rfbDl ,mgl-5 1 , 
rpsL31, kdgKSl, xyl-5, mtl-
1, argE3, thi-1 ,uvrA6 
do 
AB2463 ¥', thr-1, ara-14, leuB6, A 
(gpt-proA)62, lacYl, tsx-33, 
supE44, galK2,X~, rac', his 
G4, rfbDl, recA13,rpsL31, 
kdgKSl, xyl-5, mtl-1, argE3, 
thi-1 
do-
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AB2494 F", thr-1, ara-14, 
leuB6,di(gpt-proA)62, 
lacYl, tsx-33, supE44, 
galK2, X~, rac-,hisG4(Oc), 
rfbDl, mgl-51, rpsLSl, 
kdgKSl, xyl-5, mtl-1, 
metBl,thi-l, lexAl 
KL403 F", ara-14, leuB6A, lacZ36, 
proC32,X- . hisF860. 
thyA54, rpsE2U5, rpsL109, 
malA38, xyl-5, mtl-1,polAl, 
thi-1 
Barbara. J. Bachamnn 
E. coli Genetic Stock 
Centre, Department of 
Biology, 3550ML. Yale 
University, Post Box # 
6666, New Haven, CT, 
USA 
- d o -
XLl-Blue recA(rech\,lac', end Al, Dr. J.H. Parish 
gyr A96, thi, hsdRll, Dept. of Biochem.& 
supEAA, relK\, {¥\prokB, H^,^ • ^ ^ ^} ' ' V "TV-, 
^ ^ of Leeds, Leeds LS2 
/acA lacZAMlS, TnlOj) 9JT, UK 
Strain of phage lambda used in this study is tabulated as under 
Virulent strain; contains an absolut defective mutation in 
the immunity region and therefore forms clear plaques. 
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METHODS 
Assay of S,nuclease hydrolysis 
The enzyme assay was done by estimating the acid soluble nucleotides 
released from DNA as a result of enzymetic digestion. The reaction 
mixture (0.5 ml) contained 10.0 mM Tris-HCl ( pH 7.4) and 500.0 i^g 
calf thymus DNA (native, denatured or uric acid treated). The reactions 
were started by the addition of Cu(II) or other metal ions. All solutions 
were autoclaved before use. 
S. nuclease digestion of the mixtures was carried out in a total volume 
of 1.0 ml by adding acetate buffer (0.1 M, pH 4.5), 1.0 mM ZnSO^ and 
20 - 30 units of S,nuclease enzyme. The reaction mixtures were 
incubated for 2.0 hours at 48°C. The reactions were stopped by adding 
0.2 ml of bovine serum albumin (10.0 mg/ml) and 1.0 ml of 14% 
perchloric acid (ice cold). The tubes were immidiately transferred to 
0°C for atleast 1 hour before centrifugation, to remove the undigested 
DNA. Nucleotides were determined in the supernatant using the 
diphenyl-amine method of Schneider (1957). To a 1.0 ml aliquot, 2.0 
ml diphenyl reagent (freshly prepared by dissolving 1.0 gm of 
recrystallized diphenylamine in 100.0 ml of glacial acetic acid and 2.75 
ml of cone. H^SO^) was added. The tubes were heated in a boiling water bath 
for 20 minutes. The intensity of blue color was read at 600 nm. 
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Detection of superoxide anion (O'^) 
Superoxide anion was detected by the reduction of nitroblue tetrazolium 
(NBT) essentially as described by Nakayamae^fl/., (1983). A typical 
assay mixture contained in a total volume of 3.0 ml, 50.0 mM potassium 
phosphate buffer (pH 8.0), 33.0 ^M NBT, 0.1 mM EDTA and 0.06% 
triton X-100. The reaction was started by the addition of uric acid. 
Immediately after mixing, the absorbance at 560 nm was measured 
under various experimental conditions against a blank which did not 
contain uric acid. To confirm the formation of O"'^, superoxide 
dismutase (SOD) was added to the reaction mixture before adding uric 
acid. 
Singlet oxygen (^ O^ ) monitoring 
Formation of singlet oxygen (^O.) was determined in aquous solution 
by the method of Kralijic and Mohsini (1978). p-nitrosodimethyl 
aniline (pRNO, 16.6 ^M) solution was prepared in 10.0 mM phosphate 
buffer (pH 7.8.). Histidine (33.3 ^ig/ml) was added to pRNO solution 
as a selective acceptor of ^O.. Irradiation by under fluorescent light of 
the reaction mixture was performed for varying time periods of 
incubation. Singlet oxygen forms a transannular peroxide intermediate 
complex with histidine, leading to the bleaching of pRNO,which was 
then measured spectrophotometrically at 440 nm. The generation of 
singlet oxygen in the reaction system was further established by 
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carrying out quenching studies with sodium azide (Joshi, 1985). 
Estimation of hydroxy! radical (OH) 
Hydroxy! radical (OH') formation was determined by the aromatic 
hydroxylation method. The assay is based on the ability of OH' to 
hydroxylate aromatic rings at almost diffusion controlled rates and the 
measurement of hydroxylated products by simple colorimetric method 
using salicylate (2-hydroxy benzoate) as a detector molecule (Richmond 
et al, 1981). The reaction mixture (2.0 ml) contained the following 
reagents at the indicated concentrations: 2.0 mM salicylate, 0.1 mM 
EDTA, 0.1 mM Cu(II) and 50.0 mM KH^PO^-KOH buffer (pH 8.0). 
The reactions were initiated by the addition of appropriate amounts of 
uric acid and the tubes were incubated for half an hour at room 
temperature. Reactions were stopped by adding 80.0 ^l of 11.6 M HCl 
and 0.5 gm NaCl, followed by 4.0 ml of chilled diethyl ether. The 
contents were mixed by vortexing for 1 minute. Next, 3.0 ml of upper 
ether layer was pipetted out and evaporated to dryness in a boiling tube 
at 40''C. The tubes were cooled and the residue dissolved in 0.25 ml 
of cold distilled water to which, the following reagents were added in 
the order stated: (a) 0.125 ml of 10% w/v TCA dissolved m 0.5 M HCl, 
(b) 0.25 ml of 10% w/v sodium tungstate (in water) and (c) 0.25 ml of 
0.5% w/v sodium nitrite (NaNOj) (freshly prepared). After standing for 
5 minutes, 0.5 M KOH was added and the absorbance at 510 nm was 
read exactly after 1 minute. 
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Stoichiometric titration of Cu(I) production 
The concentration of Cu(I) produced in the uric acid-Cu(II) reaction 
mixture was determined by titration with bathocuproine as follows : 
Uric acid (50.0 or 100.0 ^M) in 10.0 mM Tris-HCl (pH 7.5), was mixed 
with varying concentrations of Cu(II) (CUCI2) and 60.0 ^l of 10.0 mM 
stock bathocuproine aqueous solution was added to attain final 
bathocuproine concentration of 400.0 ^M, in a total volume of 1.5 ml. 
Absorbance was recorded at 480 nm. Bathocuproine is a specific Cu(I) 
chelating agent and forms intense orange complex which absorbs 
maximally at 480 nm (Jaselow and Dawson, 1951). 
Spectrophotometric study for the reduction of Cu(II) to 
Cu(I) by uric acid 
Selective sequestering agents, neocuproine and bathocuproine, were 
employed to detect reduction of Cu(II) to Cu(I) spectrophotometrically 
by recording the spectra between 320-600 nm using BeckmanDU-
40 sphectrophotometer equipped with a plotter. 
Detection by neocuproine 
The reaction mixture (1.5 ml) contained Tris-HCl (pH 7.5), 0.1 mM 
uric acid, 0.2 mM Cu(II) and 0.4 mM neocuproine. The reaction was 
started by the addition of Cu(II). 
33 
Detection by bathocuproine 
The reaction mixture (1.5 ml) contained Tris-HCl (pH 7.5), 0.2 mM 
uric acid, 0.1 mM Cu(II) and 0.4 mM bathocuproine. The spectra were 
immediately recorded after the addition of Cu(II). 
Spectrofluoroscopy 
The fluorescence spectra of uric acid, under various conditions, as 
indicated in the 'legends', were recorded on a Shimadzu 
spectrofluorometer equipped with a calculator and plotter. Excitation 
wavelength was 280 rmi. 
Treatment of supercoiled plasmid pBR322 DNAwith uric 
acid in the presence of Cu(II) 
Plasmid pBR322 DNA was prepared by the method of Sambrook et 
al., (1989). 0.3 ^g of plasmid DNA in 20.0 i^l of Tris-HCl buffer (10.0 
mM, pH 7.5) was incubated under -500 lux of fluorescent light with 
appropriate concentrations of uric acid and Cu(II), at room temperature, 
for the time periods indicated in the 'legends'. Different metal ions were 
added in some experiments at concentrations indicated in the 'legends'. 
A sample buffer (10.0 ^l) containing 50% glycerol (v/v), 40.0 mM 
EDTA and 0.05% bromophenol blue was added to stop the reactions 
and then the samples were electrophoresed on 1.2% agarose gels in 
Tris-acetate-EDTA buffer (0.04 M Tris-acetate, 0.02 M EDTA, pH 
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8.0). The gels were stained in 0.5 ^g/ml ethidium bromide and 
photographed in UV on a UV-300 trans-illuminator. Experiments in 
which bands were extracted for subsequent studies, a small trough was 
cut into the gel just ahead of the band to be extracted. Electrophoresis 
was continued but occasionally interrupted as the stained material ie: 
DNA (viewed under UV-light) entered the trough, which was then 
emptied with a micropipette. Removal of ethidium bromide, 
concentration and subsequent treatriient of DNA extracted in this way 
was by standard methods (Sambrook et ah, 1989). 
Maintainance and growth of bacterial strains 
Each strain of E. coli was streaked on a nutrient agar plate. A single 
colony was picked up from the plate and repurified by streaking. The 
culture was tested on the basis of associated genetic markers, raising 
it from a single colony on the master plate. Having satisfied with the 
test clone, the culture was streaked on nutrient agar slants. It was then 
allowed to grow overnight at 37°C and stored at 4°C. The cultures were 
transferred on to fresh slants every month. 
Preparation of bacteriophage lambda Stock and treatment 
with uric acid and Cu(II) 
Bacteriophage stocks were prepared on plates by confluent lysis 
method (Sambrook et al., 1989). Bacteria from the exponential culture 
35 
were harvested and resuspended in 10.0 mM MgSO^ solution. 0.3 ml 
of AB1157 host cells were infected with phage lambda at a multiplicity 
of infection (m.o.i.) of 5.0, adsorption was allowed for 20 minutes at 
37°C and plated with 3.0 ml of molten soft agar on hard agar plates. 
Plates were then incubated at 37°C till confluent lysis was visible to the 
naked eye. The top agar containing phage lambda was scraped in a 10.0 
mM MgSO. solution. 1% chloroform was then added and mixed by 
gentle vortexing at 37°C. Phage was obtained in the supernatant by 
centrifugation of the above lysate at 10,000 RPM for 20 minutes at 4°C 
the phage stock thus obtained was titred and stored at 4°C over few 
drops of chloroform. 
For assay of phage inactivation, uric acid and CuCL (in sterilized 
distilled water) were added to the phage suspension (0.25 ml) in Tris-
9-1-
HCl/Mg buffer(10.0 mM each, pH 7.5). The reaction mixture was 
incubated for 4 hours at room temperature during which it was 
vortexed at 5 minute intervals. In some experiments neocuproine or 
oxygen free radical quenchers were added before the addition of 
CUCI2. After incubation, treated phage was diluted with 10.0 mM 
MgSO^ and 0.1 ml of diluted phage was added to a 0.3 ml suspension 
ofE. coli host/mutant strain. Lambda-F. coli complexes were vortexed 
for 1 minute and then incubated for 20 minutes at 37°C. After incubation 
3.0 ml of soft agar (40°C) was added to the treated phage, vortexed and 
immidiately poured on the nutrient agar plates. Plates were incubated at 37°C 
for 5 - 6 hours followed by counting of plaque forming units (PFU). 
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For the experiment in which the indicator bacteria were pre-treated 
with UV-light, cells were centrifuged (4000 RPM for 10 minutes at 
4°C), harvested, resuspended and washed three times by 0.15 sodium 
chloride and 0.015 M potassium phosphate buffer, pH 7.5 and the final 
suspension (10^ cells/ml) was poured into a sterilized petridish to a 
depth of 3.0 mm. The cells in the dish were exposed to UV-light by an 
uncalibrated UV-lamp for 25 minutes. For experimental assays, the 
viability of the cells used was determined by dilution and plating on 
nutrient media. 
Bacterial transformation 
Competent cells were prepared by standard method (Sambrook et al, 
1989) with modifications. An overnight bacterial culture of XLl-Blue 
was centifuged at 4000 RPM for 5 minutes at 4°C. The supernatant was 
discarded and the bacterial pellet was resuspended in half of the 
original culture volume of an ice cold solution of 70.0 mM calcium 
chloride and 10.0 mM Tris-HCl (pH 8.0). Cell suspension was placed 
on an ice bath for 20 minutes, recentrifuged, supernatant was discarded 
and cells resuspended in, 1/15th of the original culture volume of, an 
ice cold sterile solution of CaCL-Tris-HCl buffer(pH 8.0) and left on 
ice for 20 minutes. Cells were harvested by centrifugation, suspended 
in 0.2 ml of CaCl2-Tris-HCl buffer and left overnight at 4°C. For each 
transformation mixture, 40.0 ng of pBluescript SK+/- (pBS) DNA in 
Tris-HCl buffer (10.0 mM Tris-HCl, pH 7.5) was added to 0.2 ml of 
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competent cells. The mixture was stored on ice for 30 minutes. The 
cells were given a heat shock by incubating the above mixture for 2 
minutes on a preheated (42°C) water bath. 0.8 ml of Luria broth (LB) 
was added to each reaction mixture and the tubes were incubated at 
37°C for 1 hour without shaking and then plated. 
Minipreparation of plasmid DNA 
Plasmid DNA was isolated from transformed cells in minipreps 
essentially according to Sambrook et al. (1989). Starting with a single 
colony of transformants, the culture was grown overnight at 37°C in 
nutrient broth in the presence of respective antibiotic marker (Ampicillin, 
50.0 i^g/ml and/or Tetracyclin, 10.0 |ig/ml). A 1.5 ml of culture was 
pelleted in a microcentrifuge. The pellet was resuspended in 100.0 fil 
of lysis buffer (50.0 mM Tris-HCl, pH 8.0, 10.0 mM EDTA and 50.0 
mM glucose) and kept for 5 minutes at room temperature, followed by 
the addition of alkaline SDS solution (1% SDS in 0.2 N NaOH). The 
suspension was incubated on ice for 5 minutes after vortexing. 150.0 
i^l of 3.0 M potassium acetate buffer (pH 5.5) was then added and the 
suspension was reincubated on ice for 5 minutes. The mixture was 
centrifuged at 10,000 RPM for 5 minutes at 4°C and the supernatant 
was carefully transferred to a fresh eppendorf tube. RNaseA (20.0 ^g/ 
ml) was added and the solution was incubated at 37°C for 20 minutes, 
followed by the addition of equal volume of tris-saturated 
phenol xhloroform. The aquous phase was extracted after centrifugation 
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of the suspension for 30 seconds. The aquous phase was transferred 
to a fresh tube, 2.5 volumes of ethanol added to it and the tube was left 
overnight at -20°C for precipitating the DNA. The DNA was pelleted 
by centrifugation at 10,000 RPM for 5 minutes at 4°C, rinsed with 70% 
ehanol and repelleted by centrifugation for 2 minutes. The DNA pellet 
was dissolved in 16.0 \i\ of sterilized deionized water and 4.0 |il of 4.0 
M NaCl and 20.0 \x\ of 13% polyethylene glycol (PEG) was added. The 
solution was mixed and then incubated on ice for 20 minutes, followed 
by pelleting of DNA by centrifugation for 10 minutes. The pellet was 
suspended in 1.0 ml of 70% ice cold ethanol, centrifuged for 5 minutes 
and the DNA pellet was dissolved in 20.0 \i\ of 10.0 mM Tris-HCl, pH 
7.5 after vaccum drying. Aliquots of this DNA solution were used as 
required. 
a-complimentation assay 
Bacteria for a-complementation assay were tested essentially according 
to Samhrooket al. (1989). ToapremadeLB plate containing appropriate 
antibiotic, 40.0 ^l of a stock solution of X-gal (2.0 mg/ml in 
dimethylformamide) and 4.0 nl of IPTG solution (200.0 mg/ml in 
sterilized deionized water) was spread using a sterile glass spreader 
and the plate left at 37°C for 3 - 4 hours untill all of the fluid had 
evaporated. The plate was then inoculated with bacteria to be tested 
by spreading 100.0 ^l of bacterial suspension over the agar medium. 
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After the inoculum had adsorbed, the plate was incubated at 37°C for 
12-16 hours, after which it was stored at 4°C for several hours (this 
allows the blue color to develop fully). Colonies containing active 6-
galactosidase are pale blue at the center and dense blue at their 
periphery. White colonies (inactive 6-galactosidase) occasionally 
showed a faint blue spot in the center, but are colorless at the periphery. 
Isolation of mutants and DNA sequencing 
Competent XL 1 -Blue cells were transformed by uric acid-Cu(II) treated 
plasmid Bluescript SK+/- DNA as above. White colonies were isolated 
and replated in order to confirm the mutant phenotype. DNA was 
isolated from the confirmed mutants and sequenced by the method of 
Sanger et al. (1977) using an Ml3 universal sequencing primer (17 
mer) with a 3'-0H terminus (5'-0H-GTAAAACGACGGCCAGT-
3'OH), complementary to the /acZa coding sequence. 
Electrophoresis and autoradiography 
Products of extension were fractionated by electrophoresis on 8% 
acrylamide gels containing 8.0 M urea in THE buffer (12.1 gm Tris + 
5.1 gm boric acid+0.37 gm EDTA, pH 8.3). Following electrophoresis at 3000 
volts DC, gels were soaked in 10% acetic acid for 10 minutes, transferred to 
a Whatman 3.0 mm paper, dried under vaccum at 70°C and then subjected to 
autoradiography against an intensifying screen for 24 - 36 hours at -70°C. 
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Restriction analysis of the plasmids isolated from the 
transformants and agarose gel electrophoresis 
0.5 ^g of DNA isolated from the transformants was digested in 20.0 \i] 
of appropriate restriction buffer in which restriction endonuclease was 
present in excess of the units required for complete digestion. The 
reaction mixture was incubated at 37°C for 1 hour. A sample buffer 
containing 0.25% bromophenol blue, 40.0mM EDTA, 0.25% xylene 
cyanol FF and 40% (w/v) sucrose (in water) was added to stop the 
reactions. The samples were electrophoresed on 1% agarose gels, 
stained and photographed in UV-light on a UV-300 transilluminator. 
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RESULTS (Part I) 
DNA breakage induced by uric acid in presence of Cu(II) 
Figure 3, gives the S.nuclease hydrolysis of native calf thymus DNA 
with increasing concentration of uric acid in the presence of Cu(II). A 
higher temperature of 48°C was used for enzyme incubation in order to 
expose the relatively less stable secondary structures in DNA to the 
enzyme. There is a gradual increase of DNA degradation with increasing 
uric acid concentration (upto 5.0 mM). Controls using untreated 
double-stranded DNA and denatured DNA showed -10% and 100% 
acid soluble hydrolysis respectively (data not shown). Thus, uric acid 
in the presence of Cu(II) transforms DNA into an effective substrate for 
S.nuclease, suggesting a destablization of the secondary structure of 
DNA, possibly, through the formation of strand breaks. The strand 
scission induced by uric acid and Cu(II) is also dependent upon Cu(II) 
concentration. The results given in Figure 4, indicate that DNA 
degradation is a function of Cu(II) concentration. The reaction is 
progressive and no plateau is observed upto a concentration of 2.0 mM. 
Time dependency of DNA breakage induced by uric acid 
and Cu(II) in light and dark 
The kinetic behaviour of DNA fragmentation reaction is shown in 
Figure 5. It is apparent that under flourescent light (-500 lux) the 
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FIGURE 3 : DEGRADATION OF CALF THYMUS DNA AS A 
FUNCTION OF INCREASING URIC ACID 
CONCENTRATION AS MEASURED BY THE 
DEGREE OF S,NUCLEASE DIGESTION 
DNA was incubated with increasing concentrations of 
uric acid in the presence of 5.0 mM Cu(II) at room 
temperature for 5 hours under fluorescent light. 
S,nuclease digestion and determination of acid soluble 
material was done as described in the 'Methods'. 
2 3 A 
UricAcid(mM) 
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FIGURE 4 : DEGRADATION OF CALF THYMUS DNA AS A 
FUNCTION OF INCREASING Cu(II) CONCEN-
TRATION AS MEASURED BY THE DEGREE OF 
SjNUCLEASE DIGESTION 
DNA was incubated with increasing »^uiiuciiiiiiuuiis ui 
Cu(II) in the presence of 1.0 mM uric acid at room 
temperature for 5 hours under fluorescent light. 
S J nuclease digestion and determination of acid soluble 
material was done as described in the 'Methods'. 
0.5 1 1.5 
Copper( I I ) (mM) 
2.5 
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FIGURE 5 : TIME DEPENDENCY OF DNA BREAKAGE 
INDUCED BY URIC ACID AND Cu(II). EFFECT 
OF INCUBATION l^ LIGHT AND PARK 
DNA was incubated withxl.O mM uijc acia in the 
presence of 1.0 mM Cu(II) at room temperature for 5 
hours under fluorescent light and, in darkness 
respectively, for the indicated time and then subjected 
to S^nuclease digestion. 
( • ) Light 
(O) Dark 
2 3 A 5 
Time (Hours) 
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damage increases with increasing time of incubation and is linear 
during the assay period (0 - 6 hours). It is further seen (Figure 5) that, 
in dark the degradation of DNA is considerably reduced but does show 
a linear relationship with time. In order to directly demonstrate that the 
susceptibility of DNA to S.nuclease, in the presence of uric acid and 
Cu(II), is due to the formation of strand breaks and not due to the 
creation of single stranded regions in the duplex, superhelical plasmid 
DNA was used. 
Cleavage of pBR322 DNA by uric acid and Cu(II) 
In the presence of Cu(II), uric acid induced strand breakage in DNA by 
converting superhelical (Form I) plasmid pBR322 DNA to circular 
nicked relaxed Form II DNA. Figure 6A, shows the ethidium bromide 
stained band pattern of pBR322 DNA treated with increasing 
concentration of Cu(II) in the presence of 0.5 mM uric acid (Lanes c 
- h). As can be seen the treatment of Form I DNA with Cu(II) at 
concentrations upto 0.1 mM does not cause any change in the intensity 
of Form I DNA (Lanes c and d). At 0.3 mM Cu(II), there was complete 
conversion of Form I DNA to Form II (Lane e). However, no linears 
were seen on increased concentration of 0.5 mM and 1.0 mM Cu (II) 
(Lanes f and g). Further it is seen that under the conditions used 
conversion to the relaxed form is also achieved in dark (Lane h). 
The breakage induced by uric acid and Cu(II) is also dependent on uric 
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acid concentration. Lanes b and c, in Figure 6B, show the concomitant 
decrease in the intensity of Form I DNA and simultaneous increase in 
that of Form II. At uric acid concentrations above 0.05 mM almost all 
superhelical Form I is converted to relaxed Form II DNA (Lanes d and 
e). At 0.5 mM and 1.0 mM uric acid concentration (Lanes f and g) Form 
III (Linear) DNA is also observed. When the reaction was incubated 
in dark, conversion of Form I DNA to Form II and Form III is also 
observed (Lane f). 
One explanation of the above results could be that, at higher 
concentrations, uric acid remains bound to DNA even after the cut has 
been made and dissociates rather slowly. This is further strengthened 
by the results obtained in Figure 7, which shows the time dependent 
conversion of Form I DNA to Form II and Form III. Lanes b - g reveal 
that although conversion of Form II to Form III DNA increases with 
increasing time of incubation it does not reach completion even after 
5 hours. 
Effect of transition metal ions on degradation of DNA by 
uric acid 
Figure 8, shows the effect of different metal ions on the degradation of 
pBR322 DNA by uric acid. Of several metal ions tested only Fe(III), 
and Cu(II) (Lanes b and c) complemented uric acid in the DNA 
breakage reaction. Extent of reaction was quantified by using calf 
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FIGURE 6 : AGAROSE GEL ELECTROPHORETIC 
PATTERN OF ETHIDIUM BROMIDE STAINED 
PBR322 DN A AFTER TREATMENT WITH URIC 
ACID AND Cu(II) 
DNA migrated from top to bottom in the order of 
decreasing distance of Form I DNA (Supercoiled 
covalently closed circular DNA), Form III DNA (Linear 
duplex DNA) and Form II DNA (Relaxed circular 
DNA). 
(A) Effect of increasing concentrations of Cu(II) on 
uric acid mediated degradation of pBR322 DNA. Lane 
a: DNA alone; Lane b: 0.5 mM uric acid. Lanes c - g: 
0.05, 0.1,0.3,0.5,1.0 mMCuCl2; Lane h: 0.5 mM uric 
acid and 1.0 mM CUCI2, incubated in dark. 
(B) Conversion of DNA from Form I to Form II as a 
function of increasing uric acid concentration. Lane a: 
pBR322 DNA; Lanes b - g : 0.025, 0.05, 0.1, 0.3, 0.5, 
1.0 mM; Lane h: 1.0 mM uric acid (in dark); in the 
presence of 0.5 mM Cu(II). 
The reaction mixtures were incubated under flourescent 
light at room temperature for 4 hours, except lane: h in 
(A) and (B), which were incubated in dark. 
a b c d e f g h 
SC 
oc 
A 
a b c d e f g h 
SC 
B 
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FIGURE 7 : KINETIC BEHAVIOUR OF DNA BREAKAGE 
INDUCED BY URIC ACID AND Cu(II) 
Reaction mixtures containing 0.5 mM uric acid and 
0.5 mM Cu(II) 04 were incubated in the presence of 
fluorescent light at room temperature for the time 
periods indicated. Lanes a: pBR322 DNA; Lanes b -
g : 0, 1, 2, 3, 4 and 5 hours. 
a b c d e f g 
UN 
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FIGURES : EFFECT OF ALTERNATIVE METAL IONS ON 
URIC ACID MEDIATED DEGRADATION OF 
pBR322 DNA 
Reaction mixtures were incubated under fluorescent 
light at room temperature for 4 hours. Lanes a and n: 
DNA alone; Lanes b - g: 0.5 mM uric acid and 0.5 mM 
Fe(III), Cu(II), Mn(II), Ca(II), Mg(II) and Co(II) 
respectively, in the presence of DNA. Lanes h - m: 
controls; 0.5 mM Fe(III), Cu(II), Mn(II), Ca(II), Mg(n) 
and Co(II) respectively, in the presence of DNA 
a b c d e f g h i j k l m n 
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TABLE II: S, NUCLEASE HYDROLYSIS FOLLOWING DAMAGE 
TO DNA TREATED WITH URIC ACID IN THE 
PRESENCE OF TRANSITION METAL IONS IN LIGHT 
Sample % DNA hydrolyzed 
Control (DNA alone) 10.2 
DNA + Uric acid 10.2 
DNA + Uric acid + Cu(II) 39.0 
DNA + Uric acid + Mn(II) 17.3 
DNA + Uric acid + Co (II) 10.8 
DNA + Uric acid + Mg (II) 11.6 
DNA + Uric acid + Ca(II) 14.5 
DNA + Uric acid + Ni (II) 10.2 
DNA + Uric acid + Fe (III) 24.5 
DNA + Uric acid + Fe (II) 13.0 
Treatment of calf thymus DNA (2.0 mg/ml) in Tris-HCl (10.0 mM, pH 
7.5) with uric acid (1.0 mM) was carried out with respective metal ions 
in sterile tubes at room temperature under the fluorescent light (-500 
lux) for 5 hours. At the end of incubation period the reaction mixtures 
were subjected to S^nuclease hydrolysis in the standard assay. 
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thymus DNA as the substrate (Table II). Only Fe(III) and Cu(II) 
complemented uric acid in generating Sj sensitive sites significantly. At 
similar concentration, in the absence of uric acid no DNA degradation 
was observed. 
Effect of anaerobic conditon, dark and free radical 
scavengers on DNA breakage by uric acid and Cu(II) 
Several polycyclic aromatic compounds such as 4-(9-acridinylamino) 
methanesulfon-m-anisidide (Wong et al., 1984), 1,10-phenenthroline 
(Gutteridge and Halliwell, 1982), bleomycin (Suguira, 1979; Ehrenfeld 
et al., 1987), adriamycin (Eliot et al., 1984) and flavonoids (Rahman 
et al., 1989) have been shown to degrade DNA in the presence of a 
metal ion and oxygen. In all these reactions active oxygen species, 
such as hydroxyl radical and singlet oxygen were shown to be responsible 
for breakage of the DNA molecule. For this reason the requirement of 
molecular oxygen and also the affect of several free radical scavengers 
or inhibitors on uric acid-Cu(II) mediated DNA degradation were 
examined. Sodiimi azide is a singlet oxygen scavenger. Superoxide 
dismutase (McCord and Fridovich, 1969) and catalase remove 
superoxide anion and hydrogen peroxide, respectively. Sodium 
benzoate, mannitol and potassium iodide eliminate hydroxyl free 
radicals. As shown in Table III, DNA cleavage was inhibited to about 
92% under anaerobic condition, indicating the requirement of molecular 
oxygen in the DNA breakage. Sodium azide substantially inhibited the 
-54 
iAmi:m: PERCEivr isHmmav or S,NUCLEASE HYDROLYSIS 
OFDNA AFTER TREATMENT WITH URIC ACID 
AND CU(II) IN THE PRESENCE OF SCAVENGERS 
OR UNDER ANAEROBICCONDITIONS AND IN 
THE ABSENCE OF LIGHT 
Scavengers or anaerobic % inhibition of S^nuclease 
Condition hydrolysis 
Thiourea (100.0 mM) 22.06 
Sodium azide (100.0 mM) 80.20 
Catalase(0.1 mg/ml) 71.75 
Mannitol (100.0 mM) 50.27 
Potassium iodide (100.0 mM) 37.85 
Dark 87.00 
Anaerobic condition 91.66 
Boiled catalase (0.1 mg/ml) 11.86 
Superoxide dismutase (0.1 mg/ml) 60.45 
Concentrations shown are final reaction concentrations details of reaction 
mixture are given in 'Methods'. 
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breakage, indicating the involvement of singlet oxygen in the degradation 
reaction. The uric acid-Cu(II) induced DNA degradation was 
significantly inhibited by the addition of catalase (71.75%) and its 
protective activity was mostly destroyed by heat-denaturation 
confirming the involvement of hydrogen peroxide in the DNA 
degradation reaction. Superoxide dismutase, potassium iodide, sodium 
benzoate and mannitol also inhibited DNA fragmentation reaction 
suggesting that superoxide and the hydroxyl radicals may also be 
involved. Significant inhibition of DNA degradation in dark (87%) 
suggests that, light is essential for uric acid-Cu(II) induced DNA 
breakage. 
Inhibition of uric acid-Cu(II) induced DNA breakage by 
neocuproine 
It was of interest to determine whether the production of Cu(I) during 
uric acid-Cu(II) interaction was necessary for DNA breakage. For this 
purpose, a Cu(I) specific chelating agent, neocuproine, was added to 
the uric acid-Cu(II)-DNA reaction mixture. Neocuproine forms a 
stable complex with Cu(I) in aquous solutions. Previously in our lab 
(Rahman et al., 1989; Bhat and Hadi, 1992) and others (Que et al., 
1980) have confirmed (data not shown) that the neocuproine-Cu(I) 
complex does not hydrolyze DNA. The inhibition of DNA breakage 
was examined by using a single ratio of uric acid and Cu(II) and varying 
amounts of neocuproine. When increasing concentrations of 
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neocuproine were added, there was a progressive decrease in the 
S.nuclease susceptibility to DNA. Results, in Figure 9, show that the 
percent inhibition of DNA degradation is a function of the ratio of 
neocuproine/Cu(II). The percent inhibition of DNA degradation was 
calculated as (A-B)/A x 100 (A and B are the % DNA hydrolyzed in the 
absence and presence of neocuproine, respectively). The percent 
inhibition plateaued at a ratio of 2, regardless of the ratio of uric acid 
and Cu(II) used in the mixture. The uric acid-Cu(II) stoichiometry 
obtained agrees with the reported neocuproine-Cu(II) complex 
formation, consistent with the simple sequesteration mechanism for 
inhibition, as the stoichiometry of neocuproine/Cu(I) complex is 2:1 
and also, confirming that Cu(I) is an essential intermediate in the 
reaction. Cu(I) alone upto concentrations of 200.0 ^M does not cause 
any breakage of DNA (data not shown). This was determined by 
incubating Cu(I) with DNA and subjecting it to S.nuclease hydrolysis. 
Production ofu(I) fr om uric acid-Cu(II) interaction 
To determine whether uric acid-Cu(II) interaction results in the reduction 
of Cu(II) to Cu(I), two Cu(I) specific chelating agents, bathocuproine 
and neocuproine, were employed. Bathocuproine forms an intense 
orange complex which absorbs maximally at 480 nm (Jaselow and 
Dawson, 1951). Neocuproine, on the other hand, complexes with 
Cu(I) to form Cu(neocuproine)2^ complex, which has an absorption 
peak at 450 nm (Nebesar, 1961). 
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FIGURE 9 : INHIBITION OF URIC ACID-Cu(II) INDUCED 
DNA BREAKAGE BY NEOCUPROINE 
DNA was treated with 1.0 mM uric acid and 1.0 mM 
Cu(II) in the presence of varying concentrations of 
neocuproine at room temperature for 5 hours under 
fluorescent light and then subjected to S.nuclease 
digestion. 
2 3 A 
Neocuproine/Cu(II} 
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Figure 10 and Figure 11, illustrate that Cu(II) does not react with either 
chelating agent. However, when Cu(I) was added to bathocuproine or 
neocuproine containing solution, absorption peaks at 480 and 450 nm 
respectively, were obtained. Addition of bathocuproine to the uric 
acid-Cu(II) mixture yielded Cu(I) specific product which had an 
absorption peak at 480 nm (Figure 10) and with neocuproine, a 
reaction product which had an absorption peak at 450 nm was obtained 
(Figure 10). This indicates that Cu(I) is produced during uric acid-
Cu(II) interaction. No significant spectral changes in the absorption 
spectrum of uric acid were obtained with either bathocuproine or 
neocuproine alone. 
Stoichiometry of uric acid-Cu(II) interaction 
To determine the amount of Cu(I) produced in the uric acid-Cu(II) 
reaction, bathocuproine was employed. The Cu(Bathocuproine)2^ 
complex (5 = 13500 M"^  cm'') (Jaselow and Dawson, 1951) absorbs 
maximally at a wavelength (X = 480 nm) that is far separated from 
the absorption of uric acid {X = 290 nm). Thus, the presence of uric 
acid does not interfere with the measurement of Cu(II) produced to any 
significant extent. 
Figure 12, illustrates the Job plots (Wong etaJ., 1984) of the absorbance 
at 480 nm vs. uric acid/Cu(II) ratio. When uric acid was mixed with 
increasing concentration of Cu(II), there was an increase in the Cu(l) 
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FIGIIRE 10 : DETECTION OF URIC ACID-INDUCED Cu(I) 
PRODUCTION BY BATHOCUPROEVE 
The concentration of bathocuproine used was 0.4 mM. 
( o o ) Bathocuproine + Cu(II) [0.1 mM] 
( • • ) Bathocuproine + Cu(I) [0.025 mM] 
(A A) Bathocuproine + Uric acid [0.2 mM] 
(^ >|«) Uric acid+Cu(II)+Bathocuproine [0.4mM] 
(A A) Bathocuproine 
Bathocuproine was added immediately after 
mixing of uric acid and Cu(II). 
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FIGURE 11 : DETECTION OF URIC ACID INDUCED Cu(I) 
PRODUCTION BY NEOCUPROEVE 
(. ) Neocuproine + Cu(II) [0.2 mM] 
( — ) Neocuproine + Cu(I) [0.025 mM] 
( ) Neocuproine + uric acid [0.1 mM] 
(—^ x—) Uric acid+Cu(II)+ Neocuproine [0.4 mM] 
Neocuproine was added immediately after mixing of uric 
acid and Cu(II). 
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production as evidenced by an increase in A^^ ^ in the presence of 
bathocuproine. Both with 0.05 mM as well as 0.1 mM uric acid, the 
maximum A^^^ is achieved at Cu(II)/uric acid ratio of 1.75. From the 
absorption data (A. ) shown in Figure 12, the amounts of Cu(I) 
produced were calculated and are shown in Table IV. The data suggest 
that addition of 1 equivalent of Cu(II) produced 1 equivalent of Cu(I) 
at concentrations below the equilibrium levels. 
Photogeneration of superoxide anion (O *') by uric acid 
on illumination under the fluorescent light 
Figures 13 and Figure 14, show the generation of superoxide anion by 
uric acid in the visible light. The increase in absorbance, at 560 nm, 
observed on reduction of nitroblue tetrazolium (NBT) by superoxide 
anion is substantially reduced in dark and is almost completely inhibited 
in the presence of superoxide dismutase (Figure 13) indicating that the 
method genuinely assays the superoxide anion. This is also consistent 
with DNA degradation by uric acid-Cu(II) where little hydrolysis of 
DNA is seen in dark. 
Figure 14, shows the generation of superoxide anion at different 
concentrations of uric acid as a function of time. From the Figure it is 
evident that the production of superoxide radical increases with 
increasing concentration of uric acid and increasing time of incubation. 
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FIGURE 12 : STOICHIOMETRY OF URIC ACID-Cu(II) 
INTERACTION 
The concentrations of uric acid used were 0.05 mM 
( • )and 0.1 mM( O ) The absorbance difference at 
480 nm (A^g^) of the samples with or without Cu(II) 
addition is plotted vs. the equivalents of Cu(II) added 
per equivalent of uric acid. The X-axis value at the 
intersection of the two lines is taken to represent the 
ratio of Cu(II) to uric acid. The values obtained here 
at both concentrations of uric acid are 1.75 equivalents 
of Cu(II) to 1 equivalent of uric acid. 
2 A 6 8 
Equivalent Cu(n }/Uric Acid 
10 
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TABLE IV: PRODUCTION OF CuO) FROM URIC ACID-Cu(II) 
INTERACTION AS CALCULATED FROM 
SPECTROSCOPIC DATA 
Cu(II) added (mM) A^^^^ Cu(I) produced '^C^m) 
(A) 0.05 mM Uric Acid 
0.0125 0.2070 15.3 
0.0250 0.4030 29.8 
0.0375 0.6570 48.6 
0.0500 0.8000 59.2 
0.0750 1.1250 83.3 
0.0875 1.3010 96.3 
0.1000 1.3540 100.2 
0.1500 1.3540 100.2 
0.2500 1.3540 100.2 
0.3000 1.3540 100.2 
0.4000 1.3540 100.2 
(B) 0.1 mM Uric acid 
0.025 0.4240 31.4 
0.050 0.8120 60.1 
0.075 1.3140 97.3 
0.100 1.6020 118.6 
0.150 2.2620 167.5 
0.175 2.6040 192.8 
0.200 2.7080 200.5 
0.300 2.7080 200.5 
0.500 2.7080 200.5 
0.600 2.7080 200.5 
0.800 2.7080 200.5 
:^ Assays were carried out as described in'Methods'. 
**: A^^ was obtained from A ^ of samples minus A^ ,^ of uric acid with no 
Cu(II) addition. 
^. Concentration of Cu(I) was calculated by the eqution A = ^  cl, in which, 
G= 13500 M-^cm-' and 1 = 1 cm. 
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FIGURE 13 : PHOTOGENERATION OF SUPEROXIDE 
ANION (O 2) BY URIC ACID ON ILLUMINATION 
UNDER FLUORESCENT LIGHT. EFFECT OF 
INCUBATION IN DARKNESAND SUPEROXIDE 
DISMUTASE 
The concentration of uric acid used was 6.0 mM 
( • ) Light 
( O ) Dark 
( A ) + SOD 
150 
Time (Minutes) 
250 
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FIGURE 14: PHOTOGENERATION OF SUPEROXIDE ANION 
(O p ON ILLUMEVATION OF URIC ACID UNDER 
THE FLUORESCENT LIGHT 
The photogeneration of O''^ was carried out as described 
in the 'Methods'. The concentrations of uric acid in the 
reaction mixture were: 
( • ) 0.5 mM 
( 0 ) 2.0mM 
( 1 ) 4.0mM 
(x ) 6.0mM 
100 
Tim.fM° ^°° " ° 300 T»me (Minutes) 
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TABLE V: RATE OF PRODUCTION OF SUPEROXIDE ANION 
FROM SOLUTION OF URIC ACID AS ASSAYED BY 
THE REDUCTION OF NTTROBLUE TETRAZOLIUM 
TO A FORMAZAN 
Time 
(min.) 
15 
30 
50 
65 
80 
95 
110 
125 
155 
185 
215 
245 
275 
0.5 mM Uric 
Acid 
1.8 
1.8 
2.6 
3.6 
4.4 
5.4 
5.4 
6.0 
8.2 
10.2 
12.2 
15.2 
19.4 
Formazan (n moles) 
2.0 mM Uric 
Acid 
1.8 
2.6 
4.4 
5.8 
6.4 
6.8 
7.2 
7.6 
9.2 
11.2 
14.6 
18.4 
22.8 
4.0 mM Uric 
Acid 
2.8 
4.4 
6.4 
8.2 
9.4 
10.2 
11.2 
12.2 
14.2 
16.6 
18.4 
22.8 
29.8 
6.0 mM Uric 
Acid 
3.6 
5.4 
8.4 
10.0 
11.2 
12.2 
12.6 
13.2 
17.2 
22.8 
26.2 
33.6 
41.6 
The final concentrations of uric acid were 0.5, 2, 4 and 6.0 mM. The 
incubations were performed under illumination of -500 lux from a 
fluorescent strip light. The readings were converted to nano moles by 
using the extinction coefficient of the formazan (1500) at its absorption 
maximum of 560 nm (Auclair and Voisin, 1985). 
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The data was also used to calculate the formazan formed on NBT 
reduction and is given in Table V. 
Singlet oxygen (^ O^ ) production by uric acid under the 
fluorescent light 
Singlet oxygen production was determined in aqueous solution by the 
bleaching of p-nitrosodimethyl aniline (pRNO) as described by Kralijic 
and Mohsini (1978). As can be seen from Figure 15, bleaching of 
pRNO is observed in case of uric acid treated samples, there-by 
indicating the generation of singlet oxygen. The bleaching of pRNO by 
uric acid compares well with the known producer of singlet oxygen, 
viz. riboflavin (Naseem et al., 1988). When sodium azide, a scavenger 
of *0. was added to the reaction mixture, the bleaching of pRNO 
decreased substantially, confirming the production of ^O- by uric acid. 
A parallel control of pRNO alone was run and it showed no change in 
the absorbance. These results indicate the singlet oxygen generating 
potential of uric acid under the experimental conditions. 
Generation of hydroxyl radical (OH) by uric acid and 
Cu(II) 
It is known through established mechanisms that the generation of 
superoxide anion may lead to the formation of hydrogen peroxide 
(H2O2). The hydroxyl radical is produced by the Fenton reaction. The 
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FIGUREr5:*SINlGLi:T OXYGEN (lOJ JPRQDUCTION BY 
URIC ACID IN THrFLUORESCENT LIGHT 
Generation of singlet oxygen was measured by 
recording the decrease in the absorption of p-
nitrosodimethyl aniline (pRNO) soluion (16.6 ^M in 
10.0 mM potassium phosphate buffer,pH 7.8) 
containing 10.0 mM histidine as a selective acceptor 
of ' b - . Concentration of uric acid used was 4.0 mM. 
( • ) pRNO alone 
(O ) pRNO + Uric acid + sodium azide (150.0 mM) 
( A) pRNO + Uric acid (Dark) 
( X ) pRNO + Uric acid (light) 
( A ) pRNO + RihriflnvinniCThA 
100 150 
Time (Minutes) 
200 25 
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formation of H-O. by O'" can occur by the following mechanism; 
H2O2 + Cu(I) -> OH- + OH- + Cu(II) 
Addition of a second electron to superoxide anion gives the peroxide 
ion which has no unpaired electron and is not a radical. However, 
peroxide ion at neutral pH immediately protonates to give hydrogen 
peroxide. Alternatively, in aqueous solution superoxide anion undergoes 
dismutation to form H2O2 and oxygen (Halliwell and Gutteridge, 
1984). 
202--+2H''^H202 + 02 
The superoxide anion and hydrogen peroxide interact in the presence 
of copper salts to generate hydroxyl radical in the Haber-Weiss reaction 
(Haber and Weiss, 1934; Beauchamp and Fridovich, 1970). 
O •• + H , 0 , C»(Il)salt ^ ^ o j j . ^ 
2 2 2 Catalyst 2 
The following experiments showthat, hydroxyl radical is also generated 
by uric acid presumably by the above mechanism. Table VI, shows the 
effect of increasing uric acid concentration on the generation of 
hydroxyl radical as determined by the formation of hydroxylated 
salicylic acid (Richmond et al., 1981). It is seen that the formation of 
hydroxyl radical increases with an increase in the concentration of uric 
acid. 4.0 mM concentration of uric acid was used for subsequent 
experiment. 
Table VII, depicts the inhibition of the formation of hydroxylated 
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TABLE VI: FORMATION OF HYDROXYL RADICALS AS A 
FUNCTION OF URIC ACID CONCENTRATION 
Uric acid (mM) Hydroxylated product formed (nmol) 
0.25 07.1 
0.50 11.6 
1.00 - 18.7 
2.00 25.0 
4.00 34.5 
4.00 + Sodium benzoate 09.3 
Values of uric acid shown are final reaction concentrations. Cu(II) was 
present at 0.25 mM. The reaction mixtures were incubated for 30 
minutes at room temperature. Reaction conditions are described in 
'Methods'. 
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products by quenchers of hydroxy 1 radical such as benzoate, mannitol, 
thiourea and potassium iodide. The results confirm that the assay was 
genuinely measuring hydroxyl radical formation by uric acid and 
Cu(II). We interpret the different degrees of inhibition as reflecting 
different relative affinities of the inhibitors and salicylate for the 
radicals. The effect of catalase implicate H2O2 as an intermediate in 
the pathway that leads to OH* production under the experimental 
conditons. 
Restriction analysis of Form III (Linear DNA) generated 
by the treatment of supercoiled pBR322 DNA with uric 
acid and Cu(II) 
In order to see whether uric acid-Cu(II) mediated cleavage of DNA 
occurs at a preferred site or nucleotide sequence, the following 
experiment was performed. Supercoiled pBR322 plasmid DNA was 
treated with uric acid and Cu(II) for a time period which resulted in its 
complete conversion to the linear form. The linearized DNA was 
isolated, as described in 'Methods'. It was separately digested with 
EcoRl and BamHl for which there is only one site in pBR322 and 
analyzed on native agarose gel. The results are given in Figure 16. It 
can be seen that the isolated linear DNA molecule on treatment with 
EcoRl (Lane e) gives rise toa smear indicative of heterogenous sized 
fragments even though complete digestion of linear is not seen. The 
same result was also observed with BamHl (Lane f). Thus, the results 
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TABLLE VII: EFFECT OF OXYGEN RADICAL QUENCHERS 
ON THE GENERATION OF HYDROXYL 
RADICALS BY URIC ACID 
Hydroxylated % 
Quenchers product Inhibition 
formed (n moles) 
Control [Uric acid + Cu(II),0.1 mM] 
Control + Thiourea (50.0 mM) 
Control + Sodium azide (50.0 mM) 
Control + Catalase (0.1 mg/ml) 
Control + Mannitol (50.0 mM) 
Control + Sodium benzoate (50.0 mM) 
Control + Potassium iodide (50.0 mM) 
The final concentration of uric acid in the reaction mixture was 4.0 mM. 
Concentrations of scavengers shown are final reaction concentrations. 
Details of other reaction conditions are described in 'Methods'. 
34.49 
23.99 
17.2 
11.99 
14.15 
09.39 
26.13 
00.00 
30.42 
50.13 
65.21 
58.97 
72.75 
24.23 
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FIGURE 16 : RESTRICTION ANALYSIS OF FORM III 
(LINEAR DNA) GENERATED BY TREATMENT 
OF SUPERCOILED pBR322 DNA WITH URIC 
ACID AND Cu(II) 
Native gel 
Lane a 
Lane 
Lane 
Lane 
Lane 
Lane 
b 
c 
d 
e 
f 
Supercoiled pBR322 DNA (Control) 
Control + EcoRl 
Control + BamHl 
Supercoiled Form I DNA + Uric 
acid + Cu(II) (Linear Form III DNA) 
Linear DNA (Form III) + EcoRl 
Linear DNA (Form III) + Baml. 
a b c d e f 
sc \,,-
LIN 
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indicate that there is no evidence for any preferred site or sequence for 
uric acid-Cu(II) mediated strand scission in DNA. 
The formation of complexes involving DNA and uric acid 
Figure 1 7A, shows that when a solution of uric acid is excited at 280 
nm, it exhibits a fluorescence emission spectrum with a maximum 
around 365 nm (Davies etal., 1986). The addition of DNA to uric acid 
causes quenching (uric acid base pair ratio of 1:0.1) of the fluorescence. 
However, the quenching is abolished as the concentration of DNA is 
increased. Similar results are seen with denatured DNA (Figure 17B). 
DNA alone does not show any fluorescence emission between 300 -
400 nm when excited at 280 nm. Figure 18, shows the effect of sodium 
chloride on fluorescence quenching of uric acid by DNA. With increasing 
NaCl concentrations no significant change in the fluorescence quenching 
of uric acid is observed. Thus, increased ionic strength does not appear 
to affect the interaction of uric acid to DNA. These results indicate that 
uric acid is capable of binding to DNA and that such binding is not 
electrostatic in nature. 
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FIGURE 17/: EFFECT; OF DNA ON THE FliUORESCENCE 
E]ilISSION OF URIC ACID 
Excitation wavelength of uric acid was 280 nm. In (A): 
Trace 1 is the emission spectrum of native DNA alone 
\.0 mM); Trace 2 is emission spectrum of uric acid 
ilone (1.0 mM); Traces 3 - 7: are in the presence of 0.1, 
).25, 0.5, 0.75 and 1.0 mM base pair native (double 
itranded) DNA respectively. 
n (^y: frace 2 is emissioA i^pLfectrurtijbC denatured 
siiigle stranded) DNA (1 O^mM); Triaces 1, 3 and 4 -
' correspond to Traces 1 2 3 - 5 and 7 in (A^ with 
lenltpred DNA. 
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FIGURE 18 : CHANGES IN FLUORESCENCE EMISSION OF 
URIC ACID-DNA COMPLEX ON ADDITION OF 
SODIUM CHLORIDE 
The concentration of uric acid and DNA were 1.0 mM 
and 0.1 mM bp respectively. Trace 1: Native DNA 
alone; Trace 2: Uric acid alone; Traces 3,4, 5, 6 and 7: 
Uric acid-DNA and 0.05 M, 0.1 M, 0.15 M NaCl 
respectively. 
lOO.Oi 
60.0 
u 
c 
Or 
u 
«> 
I . 
O 
D 
60.0 
40.0 
20.0 
0.0 
300.0 400.0 
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DISCUSSION (Part I) 
The principal conclusions of the experiments described in Part 1 may 
be stated as follows: (i) uric acid in the presence of Cu(II) and 
molecular oxygen caused strand scission in DNA and that such 
degradation is considerably enhanced in the presence of visible light,(ii) 
Cu(II) is reduced to Cu(I), and the later is an essential intermediate in 
the DNA-cleavage reaction, (iii) the proximal DNA cleaving agents are 
the active oxygen species such as hydroxyl radical and singlet oxygen. 
The normal, physiological concentration of uric acid in plasma of 
humans is 0.2 - 0.54 mM (Murry et al., 1988) but the levels of 
compound vary widely from individual to individual (0.05 - 0.9 mM) 
and on an average are some what higher in males then in females 
(Becker, 1993). Under certain diseased conditions such as 
hyperuricemia, gout, arthritis etc., the uric acid concentration is 
increased 2 - 4 times the normal. Under certain extreme cases even 
higher values have been reported. In the present studies, the minimum 
concentration of uric acid in the presence of Cu(II), required for DNA 
cleavage is less than 0.5mM (Figures 3 and 6B). Thus, the physiological 
concentration of uric acid in blood is sufficient to cause macromolecular 
damage, provided that such molecules are accessible and free copper 
is available. Uric acid is cgjaMfeof binding copper and iron and 
therefore mobilize free^ioOsely bouna^^per and iron (Davies et aJ., 
£ - "A 
1986). It has been reported that copper io5j| in biological material are 
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invariably associated with the ubiquitous amino groups, to which they 
readily ligate (Gutteridge and Wilkins, 1983; Halliwell and Gutteridge, 
1984; Samuni etaL, 1981). Such binding does not necessarily prevent 
copper from participating in oxygen-radical reactions, but limits radical 
formation to the site of copper binding (Gutteridge and Wilkins, 1983). 
It has been reported that normal serum contains upto 8.0 ^M loosely 
bound copper. Other biological fluids may also contain similar amounts 
in the low micromolar range (Gutteridge, 1984; Rowley and Halliwell, 
1983). Loosely bound copper is defined by Gutteridge (1984) as that 
copper which is available for binding to the chelating agent 1,10-
phenanthroline. It is possible that such loosely bound copper is also 
available for binding to uric acid. However, it is realized that normal 
mechanisms for sequestering copper must be broken down before it can 
take part in such a reaction. 
A number of molecules present in human extracellular fluids are 
considered to have antioxidant function. In addition to uric acid, the 
other organic molecules having antioxidant activity are ascorbate, 
bilirubin, glucose and a-tocopherol (Halliwell and Gutteridge, 1990). 
Production of hydroxyl radicals and DNA damage by ascorbate and 
H2O2 in the presence of Cu(II) has been reported (Rowley and Halliwell, 
1983; Stoewe and Prutz, 1987). This presumably involves reduction of 
Cu(II) by ascorbic acid. Reduction of Cu(II) to Cu(I) can also be 
achieved by superoxide and compounds capable of generating 
superoxide, with or without photosensitization, can also catalyze this 
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reaction. One such class of compounds are the flavonoids which occur 
widely in the plant kingdom and are recognized as antioxidants (Larson, 
1988). We have earliar shown that flavonoids in the presence of Cu(II) 
catalyze DNA cleavage and this reaction involves the reduction of 
Cu(II) to Cu(I) by flavonoid generated superoxide anion (Rahman et 
al., 1989). In addition, strand scission of DNA by free radical formation 
is involved in reactions with several anti-cancer drugs (Wong et al., 
1984; Ehrenfeld et al., 1987; Eliot et al., 1984). In order for a Fenton 
type reaction of H O2 and Cu(I) to occur prior formation of H2O2 may 
not be necessary as it is known that the generation of superoxide anion 
may lead to the formation of H2O2 (Halliwell and Gutteridge, 1984). 
Our studies do not detract from the established antioxidant role of uric 
acid in biological fluids. However, we would like to suggest that 
irrespective of their physiological significance the present results 
support the idea that several of the biological antioxidants are themselves 
capable of generating oxygen radicals under appropriate conditions. 
It is recognized by most workers that hydroxyl radical reactions with 
DNA are preceded by the association of the complex with DNA, 
followed by the production of hydroxyl radicals at that particular site 
(Pryor, 1988). In the flavonoid-Cu(II) DNA cleavage system, we had 
proposed that, a ternary complex of flavonoid, DNA and Cu(II) is 
formed (Rahman etal., 1989). The reduction of Cu(II) to Cu(I) possibly 
occur in situ within the complex. The generation of active oxygen 
species occurs via the reoxidation of Cu(I) to Cu(II) during which 
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molecular oxygen is reduced to generate a variety of oxygen species 
including the hydroxyl radical. The formation of such a complex was 
established by us in subsequent studies (Rahman et al., 1990). We 
propose the formation of a similar complex in the above DNA, urate 
and Cu(II) system. Our studies on quenching of uric acid fluorescence 
indicate that it binds to DNA and the binding of uric acid to Cu(II) is 
already known (Halliwell and Gutteridge, 1990). It is possible that uric 
acid anion is also formed through reaction of uric acid with hydroxyl 
radicals. The anion is known to inactivate certain enzymes and may 
therefore be capable of DNA damage (Kittridge and Wilson, 1984). 
However, this would be difficult to envisage in vivo as the urate anion 
is readily scavenged by ascorbic acid (Maples and Mason, 1988). 
Partn: 
Inhibition Of Bacteriophage Lambda 
And Modification Of Flasmid DNA 
By Uric Add-Cu© 
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RESULTS (Part II) 
Effect of uric acid-Cu(II) mediated DNA damage on the 
viability of lambda phage 
In the following experiments we report that oxygen free radicals 
generated by uric acid in aquous solution cause inactivation of 
bacteriophage lambda. The inactivating activity of uric acid was 
determined by incubating phage with uric acid and Cu(II) in the 
presence of air for 4.0 hours and then measuring loss of biological 
activity. Figure 19, analyzes the loss of survival of X . as a function 
of uric acid concentration. Increasing concentrations of uric acid result 
in a progressive loss of survival of phage. Increasing concentrations of 
Cu(II) also result in a similar progressive loss in plaque forming units 
(PFU) (Figure 20). 
To determine the mechanism of phage inactivation by uric acid and 
Cu(II), we studied the affects of neocuproine, maimitol, sodium azide 
and catalase on the reaction mixture (Table VIII). Inactivating activity 
of uric acid was considerably reduced by prior addition of neocuproine, 
a chelator that sequesters Cu(I) in a form that is incapable of oxidation 
or reduction. A similar affect was also seen on the addition of oxygen 
radical quenchers, mannitol, sodium azide and catalase, indicating the 
involvement for hydroxyl radicals, singlet oxygen and hydrogen peroxide 
respectively, in phage inactivation by uric acid-Cu(II). 
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FIGURE 19 : EFFECT OF INCREASING URIC ACID 
CONCENTRATION ON THE VIABILITY OF 
PHAGE-LAMBDA IN THE PRESENCE OF Cu(II) 
The concentration of Cu(II) was 2.0 mM. Other details 
of the procedure are given in 'Methods'. 
Q. 
O 
O.S 1.0 IS 2.0 
Uric ocid (mM) 
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nCURE 20 : EFECT OF INCREASING Ci^ II) CONCENTRATION 
ON THE VIABILITY OF PHAGE-LAMBDA IN 
PRESENCE OF URIC ACID 
The concentration of uric acid was 1.0 mM. Other details 
of the procedure are given in 'Methods' 
0.5 1.0 1.5 2.0 
Copper (11 )(mM) 
-85-
TABLEVIII: EFFECT OF OXYGEN RADICAL QUENCHERS ON 
THE VIABILITY OF LAMBDA PHAGE AFTER 
TREATMENT WITH URIC ACID IN THE 
PRESENCE OF Cu (II) 
Phage 
k 
k 
k 
k 
Host 
AB1157 
AB1157 
AB1157 
AB1157 
Phage treatment 
None 
Uric acid (UA) 
UA + Cu(II) [Control] 
[Control] + Neocuproine 
(5.0 mM) 
PFU/ml 
1.25x10'° 
1.24x10'° 
3.0x10^ 
6.7x10^ 
Survival % 
of control 
100.0 
99.2 
2.4 
55.0 
k AB1157 [Control] + Sodium azide 4.8x10^ 39.34 
(100.0 mM) 
?i AB1157 [Control] + Catalase 3.4x10^ 27.86 
(O.lmg/ml) 
k AB1157 [Control] + Mannitol 2.0x10^ 16.3 
(100.0 mM) 
In all the cases concentration of uric acid and Cu(II) was 1.0 mM and 2.0 mM 
respectively. Concentrations of scavengers shown are final reaction 
concentrations, hicubation was for 4 hours, followed by dilution and plating. 
All experiments were performed in triplicates and mean values are presented. 
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Table IX, shows the sensitivity of bacteriophage lambda to uric acid-
Cu(II) and the affect of UV-irradiation on the host cells. The fraction 
of surviving phage was 0.056 and 0.46 in the case of untreated and UV 
treated host cells, respectively. It may be noted that at 1.0 mM 
concentration the fraction of phage inactivated in Table IX (0.056) 
matches the degree of inactivation in Figure 19 (~0.07). The results in 
Table IX, indicate that UV-treatment of the host bacteria enhances the 
recovery of the phage, indicating the involvement of UV-inducible 
pathway in the repair of uric acid-Cu(II) damaged DNA. In order to 
further investigate this observation certain repair defective mutants of 
E. coli, such as, uvrA, recA, polA and lex A were used as hosts. The 
results given in Table X, show that the reduction in PFU, to any 
significant extent, with respect to wild type, occurs only in the case of 
poIA mutant. This indicates that, the repair polymerase is involved in 
the repair of uric acid-Cu(II) induced lesions in DNA. 
Scoring of mutations within the non-essential lac Z gene 
by a-complimentation assay 
Vectors containing a portion of the lacZ gene provide a-complimentation 
when plated on cells containing lac I^ ZAM 15 cassette on the tetracycline 
resistant F' episome which makes them suitable for blue, white screening 
on plates supplemented with X-gal and IPTG (Short et a/., 1988). If a 
cloned insert or a mutation interrupts the /acZa-peptide, no 
complimentation occurs and the colonies appear white. The tetracycline 
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TABLE IX: SENSITIVITY OF PHAGE LAMBDA TO URIC ACID 
-Cu(II) AND EFFECT OF UV-IRRADIATION ON THE 
HOST CELLS 
Phage Host Host Pre- Phage Pre- PFU/ml Survival" 
Strain treatment treatment 
X AB1157 None Control 1.25x10^° 1 
X AB1157 None UA+Cu(II)'' 7xl0'^ 0.056 
X AB1157 UV Control 8.2x10^° 1 
X AB1157 UV UA+Cu(II)'' 3.8x10^° 0.46 
:^ The value of survival was calculated by dividing values in the presence 
of uric acid-Cu(II) by control values. 
Concentration of uric acid and Cu(n) used was 1.0 mM and 2.0 mM 
respectively. 
hicubation was done for 4.0 hours at room temperature followed by 
dilution and plating. All experiments were performed in triplicates and 
mean values are presented. 
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TABLE X : EFFECT OF URIC ACID-Cu(n) ON THE VIABILITY 
OF PHAGE LAMBDA 
Uric acid 
Host Strain + 
PFU/ml 
Cu(II)|inM] UA + Cu(n) Control* Reduction** 
Wild Type 
(ABllS?) 
Lexk 
(AB2494) 
uvrk 
(AB1886) 
reck 
(AB2463) 
polk 
(KL403) 
1+2 1.3x10^  1.3xl0'° 
1+2 
1+2 
1+2 
9x10* 
1x10' 
8x10* 
1.22x10'° 
1.25x10'° 
1.16x10 10 
1+2 4.5x10^ 1.04x10 °^ 
10 
13.5 
12.5 
14.5 
23.1 
\ Without uric acid and Cu(n) 
'': The value of reduction was calculated by dividing the control values by 
the values in the presence of uric acid and Cu(II). 
In all cases incubation was for 4 hours followed by dilution and plating. 
All experiments were performed in triplicates and mean values are presented. 
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selection for the F' eliminates the need for minimal media selection. 
Mutations within the non-essential lacZ gene for 6-ga lactosidase were 
identified by reduced a-complimentation assay of Feig and Loeb 
(1993). Figure 21, schematically outlines the assay used to identify the 
mutations induced in DNA by uric acid-Cu(II). 
Structural alterations in the plasmids isolated from the 
mutants 
pBluescript SK+/- DNA was treated with uric acid-Cu(II), as given in 
'legends' to Figure 22 and Figure 23. After transformation in E. coli 
XLl-Blue , five transformants were selected and the plasmid DNA 
isolated in minipreps. The isolated plasmids were electrophoresed on 
a 1 % agarose gel along with pBS DNA as an untreated control. As seen 
in Figure 22, all the plasmid isolates were of a similar size. These 
samples were digested with restriction endonuclease Pstl and the 
results are shown in Figure 23. Three of the plasmids (lanes c - e) gave 
linearized molecules whose sizes were also the same as the native 
plasmid. However, the digestion of two of the induced mutant plasmids 
(lanes f and g) resulted in two bands whose sizes were smaller then the 
linearized parental plasmid. This indicated the generation of another 
Pstl site in these plasmids. These results suggest that at the uric acid-
Cu(II) concentration used, the mutations caused are either single base 
substitutions or small insertions or deletions. 
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FIGURE 21 : SCHEMATIC DIAGRAM OF THE A S ^ A V USED 
TO IDENTIFY MUTATipi^S INDUCED BY 
URIC ACID AND Cu(II) 
DNA damage 
by uric acid-Cu(n) 
Plasmid Bluescript 
X->gal supplemented 
plate 
Transform into competent 
cells and plate on X-gal 
supplemented plate 
1. Isolate white mutant colonies 
2. Prepare DNA 
3. Sequence 
G A T C 
Autoradiogram 
91 -
FIGURE 22: SIZE DETERMINATION OF INDUCED 
MUTANT PLASMIDS ISOLATED FROM E. coli 
XLl-BLUE CELLS TRANSFORMED BY URIC 
ACID AND Cu(II) TREATED pBLUESCRIPT 
DNA 
Reaction of uric acid-Cu(II) with DNA, selection of 
mutants and DNA isolation is described in the 
'Methods' . Lane a: pBS DNA alone; Lane b: pBS 
DNA + EcoKl, Lanes c and d: 0.5 mM uric acid + 0.5 
mM Cu(II) treated mutant plasmids; Lanes e, f and g: 
1.0 mM uric acid + 1.0 mM Cu (II) treated plasmids. 
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A-; 
FIGURE 23: Pstl DIGESTION OF INDUCED MUTANT 
PLASMIDS 
Pstl digestion pattern of mutant plasmids. Lane a: 
Untreated pBS; Lane b: Untreated pSS-P^^I digest; 
Lanes c and d: Pstl digest of 0.5 mM uric acid + 0.5 
mM Cu(II) treated DNA; Lanes e, f and g: P^ I^ cleavage 
pattern of 1.0 mM uric acid + 1.0 mM Cu(II) treated 
DNA. Other details of the experiment are given in 
'Methods' 
a b c d e f 
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Mutation spectrum of uric acid-Cu(II) induced DNA 
damage 
Mutants unable to carry out a-complimentation (white colonies) were 
collected after treatment of pBS DNA with uric acid-Cu(II). In each of 
such experiments the mutation frequency was more than 20 fold greater 
than controls [in the absence of uric acid-Cu(II)]. The phenotype of 
each of the mutants was confirmed by picking up and growing the white 
colonies in liquid culture and replating. For sequencing. Ml 3 universal 
sequencing primer (17 mer) with a 3'-0H terminus (5'-0H-
GTAAAACGACGGCCAGT-3'OH) was used. The DNA stretch that 
was sequenced contained 118 nucleotides, in the multiple cloning 
region and multiple cloning site present within the pBS SK+/- DNA. 
Mutants thus obtained are likely to contain single base substitutions, 
deletions or insertions as they are approximately equal in size to the 
parental plasmid. Mutations presumably occur throughout the 6-
galactosidase fragment within the pBS SK+/- DNA. The distribution of 
mutations within the 118 base sequence, analyzed at two different 
concentrations of uric acid-Cu(II), are shown in Figure 24, and the 
classes of mutations are summarized in table XI. Single base 
substitutions and deletions are by-far the most frequent nucleotide 
sequence alterations. Figure 25, shows a limited spectrum of the 
spontaneous mutations from Sad to Kpnl sites. As seen from the 
Figures, background (spontaneous) mutations were generally not found 
at the positions of uric acid-Cu(n) induced mutations. As seen in Figure 24, the 
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FIGITRE 24 : MUTANTATION SPECTRUM OF URIC ACID-
Cu(II) INDUCED MUTANTS 
The DNA sequence of multiple cloning site in pBS 
SK+/- DNA is shown. The two lanes of the sequence 
shown represent the plus (+) strand of the wild type 
lacZ gene of the plasmid Bluescript. Each symbol 
above the line represents a single base change observed 
in a single mutant. 
For five independently isolated mutants (MI and Mil 
were 0.5 mM uric acid-0.5mM Cu(II) treated and 
Mill, MIV and MV were 1.0 mM uric acid-1.0 mM 
Cu(II) treated) substitutions (such as C->G 
transformations) are displayed above the wild type 
sequence. (•) represent a single base deletion and an 
arrow (t) represents a single base addition. 
Mil 
MJ 
Ml 
Mil 
C • T • 
A T • • • C 
5' AGCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACTAGTGGATCCCCCGGG 
Sac I Sac II Xma III Xba I " 'SpeT Bam HI Sma 1 " 
Mil 
MI 
MI 
Mil 
C C • A 
A • • 
CTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGAGGGG 
Pst\ fcoRI £coRV Hindm Cla\ Sail Xho\ 
Mil 
MI 
GGGCCCGGXACCCAATT 3' 
Apa I Kpn I 
M V A G A T A f C 
MIV • C GG C • • • 
Mill A T • T • • 
5" AGCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACXAGTGGATCCCCCGGG 
Sad SacW Xma III Xbal Spel BamHl Sma I 
Mill 
MIV 
MV 
M V C * • • • T f 
MIV T • • T • • € 
Mill C C • G * C 
CTGCAGGAATTCGATATCAAGOTATCGATACCGTCGACCTCGAGGGG 
Pst\ EcoVl EcoKV Hind 111 Clal Sail Xhol 
Mill 'f ^ 
MIV 1" 
MV 1" 
Mill A • G 
MIV A • 
Ml G G 
GGGCCCGGTACCCAATT 3' 
ApaI Kpn I 
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FIGURE 25 : MUTATION SPECTRUM OF SPONTANEOUSLY 
INDUCED MUTANTS 
Mutation spectrum shown is for five spontaneous 
mutants (SI - S V). Symbols and conventions are the 
same as in Figure 24. 
sv 
SIV 
SIII 
SII 
SI 
SI 
sn 
sni 
srv 
sv 
sv 
srv 
sm 
SII 
SI 
SI 
sn 
sm 
srv 
sv 
• • 
5' AGCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAACIAGT 
Sac\ SacU XmaUl Xbal Spel 
GGATCCCCCGC 
Bamm Smal 
G 
• • 
:TGCAGGAATTCGATATC4AGCTTATCGAT 
Pstl Ecovl EcoKW fiiriidm Clal 
sv 
SIV 
sm 
sn 
SI 
• • 
SI 
sn 
sm 
srv 
sv 
Sal I Xhol ApaI KpnI 
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TABLE XI: NUCLEOTIDE SUBSTITUTIONS, INSERTIONS 
AND DELETIONS IN SPONTANEOUS AND URIC 
ACID-Cu(II) TREATED pBS DNA 
^Vli V'^l'^'^^* ^ ^ r * 
INu 
A 
G 
C 
T 
Substitution 
^ G 
->c 
^ T 
^ 
• 
->A 
-^C 
^ T 
^ 
• 
^ A 
->G 
^ T 
1^  
• 
->A 
^ G 
^ C 
t 
• 
SI 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
1 
0 
0 
0 
0 
0 
0 
0 
1 
Undamaged DNA 
SII 
0 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
1 
0 
0 
1 
0 
0 
0 
0 
0 
SIII 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
1 
0 
SIV 
0 
0 
0 
0 
1 
0 
0 
0 
0 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
sv 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
MI 
0 
0 
1 
1 
1 
0 
1 
0 
0 
1 
0 
1 
0 
0 
2 
1 
0 
0 
0 
1 
Mil 
0 
0 
0 
0 
1 
0 
2 
0 
0 
1 
0 
1 
0 
0 
1 
1 
0 
1 
1 
0 
Damaged 
Mill 
0 
0 
0 
0 
1 
0 
2 
1 
1 
1 
1 
1 
1 
1 
2 
0 
1 
1 
0 
I 
DNA 
MIV 
1 
1 
1 
0 
3 
0 
1 
0 
0 
3 
1 
1 
0 
0 
2 
0 
0 
0 
1 
1 
MV 
1 
0 
0 
0 
2 
0 
1 
1 
0 
1 
2 
1 
1 
1 
1 
2 
0 
0 
0 
3 
SI, SII, SIII, SIV and SV: Spontaneous mutants; Ml and Mil: 0.5 mM unc 
acid-0.5 mM Cu(II) treated; Mill, MIV and MV: 1.0 mM uric acid-1.0 mM 
Cu(ll) treated mutants. 
This is compilation of data from Figure 24 and Figure 25. The deletions and 
insertions are single base. 
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frequency of mutations is higher in 1.0 mM uric acid-1.0 mM Cu(II) 
treated DNA (Mill - MV) as compared to 0.5 mM uric acid-0.5mM 
Cu(Il) treated DNA (MI - Mil). Also, the mutations were randomly 
distributed in all the five induced mutants and no 'hot spot' could be 
identified, except in 1.0 mM uric acid-1.0 mM Cu(II) (Mill - MV) 
treated plasmids where adenine in BamUl site was deleted in all the 
three mutants. 
As tabulated in Table XI, on the damaged templates the frequency of 
G->C transversions is comparatively higher than C-^G trans versions. 
On the other hand, the number of transition mutations was quite low. 
However, the frequency of total base deletions is significantly higher 
than the total A, T, C and G insertions. It appears that uric acid-Cu(II) 
induced mutagenesis in the pBS SK+/- system is random and that there 
is no preference for any particular site or sequence. Another notable 
point is that the restriction site for Pstl in Mil, Mill and MI V is mutated 
(Figure24). However, restriction endonuclease treatment to these 
mutants gave a single band (Figure 23, lanes c, d and e respectively), 
probably due to the generation of these restriction sites elsewhere 
outside the multiple cloning region. 
The sequences of induced mutants were analyzed on 'DNASIS 
database'(Hibico™ DNASIS, 1991) to retreive further information 
from the mutation spectrum. All five mutants showed long stretches of 
DNA homologous regions. However, the number of non-homologous 
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FIGURE26 : COMPARISON OF MAXIMUM HOMOLOGOUS 
REGIONS IN INDUCED AND pBS DNA 
Ml a^i Kfll were 0 5 mlvl uric acidrO S^ mM fcuCII) treated. 
Mill, Miy and MV were 1.0 mM uric acid-1.0 mM Cu(II) 
>eatg4, 
Othef <ifelairs ar^ ^^Ven i^if'MethWfe/Reslllts^ 
1 10 20 30 40 50 60 
pBS MciaG^acrccMxxcaaroacatxxacica^aiMnMBra^^ 
::: t: :::titii :::::: ::::::::: !t::::::::tt!s:: : :::::> : 
MI A6CAG6T0CTCCACCTCGGTG0-06CCGCTCT-GAACTAGTGGATCCCC-OCOCTQCAAG 
1 10 20 30 40 50 60 
61 70 80 90 100 110 120 
pBS OAATTOGATiaCMMJCTTATCGATItfXIGTCGMXrTCQAOGgOggOCOCg^^ 
: : : ; : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : t t : t : : : : : t : : : : : : 
MI GAATTCGATATCAAGCT • ATC6ATACCGTCGACCTC - GAGOGGGGCCCGGTACCGCAATT 
61 70 80 90 100 110 120 
1 10 20 30 
pBS AOCTOGataCTCXaCCGOOergGCGGCCGCTCIAOA-
40 50 60 
MIX AGCAG6T6CTCCACCTC66CGGC66CC6CT-TAGATACTA6TGGAACCCCC6G-CTCCAG 
1 10 20 30 40 50 60 
61 70 80 90 100 110 
pBS 
Mil GAATTCaVTATCAAGCTTATCG-TACCGTCGACCACGAGGGGGGGCGCGGTACCCAAT. 
' « f ' • ' 70 5 •" ; - 8 d / ^ ^ ' ' W ?'i;j"'ltW"^;''= 110 
'Ui<r/j:iu 
40 50 60 1 10 20 30 
pBS JIGCTQGaGCIOCACCGOQSIGGCGGCCGCm 
MI 11 A6ATGGAGCTCTAC - GC6GTGGCTGCCGCTCTAGAACTAGTGG- TCCCCCGGCCTGCAGG 
"•'.-•^1 ..••• : 1 0 - . , ;^-" i 2ft-;-"• ) - , ; - 3 0 ; j .M..::, '40^ ^ : 50 60 
61 70 80 * 90 ' 100 . 110 
M i l l AATTCCATXTr-,AA6C^pC2|$^g<UtA{ia3$pe^^ 
61 70 80 90 ' i oo '~ 110 
1 10 20 30 
pBS AQCTGGAGCTOCACCGOGGIGGCGGOCGCICI 
40 50 60 
-OCHG 
MIV AGCT6C - GCTC6GCCGGC6T6CC66CC6C - CTAGAACTAGTGG- TCCCACG6 - CTTGCAG 
1 10 20 30 40 50 60 
61 70 80 90 100 110 
• * • • • • • • • • • • • • • • • • • • • • • • • • • • • • • « • * • • * • • • • • • • • • • • • • • • 
• •••• ••• •• •••••••••••••••• ••••••••••**•• • • • « • ••••••• 
MIV GAATT-GAT-TCTAGCTTATCGATACCGT-GACCTCGAGGGGGG-CACGGT-CCCAATT 
61 70 80 90 100 110 
1 10 20 30 40 50 60 
pBS AgCTOGMCTCCaCCGCGSTqSTqgCCOCTCTAGAMTnGTg^ 
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • * • • • • • • • • * • • ! • • • « ; S S * 
MV AGATGGAGGTCCACCGCGGAGGCTGCCGCTCAAGAACTAGTGGA-CCCCCGCGCCT-CAG 
1 10 20 30 40 50 60 
61 70 80 90 100 110 
MV GA-T-CGAT-TCAAGCT-ATCGATACTGT-GACCTCGAGGGGGGGCyVCGGT-CGGGATT 
61 70 80 90 100 110 
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FIGURE 27 : SECONDARY HAIR PIN LOOP SITES AND 
SEQUENCES IN THE FRAGMENT OF URIC 
ACID-Cu(II) TREATED pBLUESCRIPT PNA 
SEQUENCED 
DNA Hairpin Loop Sequence 
XLl-Blue 
(Control) 
14 
5" CCAG 
:;CGCG 
3' GGTG 
19 
17 
5'CCGC 
. ::GGTG 
3'GGCG 
22 
Mutant I 
[0.5 mM U.A.+ 
0.5 mM Cu(II)] 
Mutant D 
[0.5 mM U.A.+ 
0.5 mM CuOn) 
5'GGTG 
: : : : C T C 
3' CCAC 
12 
22 
5'GCGG 
: : : : C G G 
3' CGCC 
14 
5' CCAC 
: : . : CTCG 
3' GGTG 
19 
17 
5'CCGC 
: : : : G G C G 
3'GGCG 
8 
5' AGGTG 
: : ; : :CTC 
3' TCCAC 
12 
20 
5'CGGC 
: : : :GGCG 
V GCCG 
S5 : 
20 
5'GCGGC 
: : : ; : GGC 
3' CGCCG 
: 25 
Mutant m 
[1 mM U.A. + 
1 mM Cu(II)] 
Mutant IV 
[1 mM U.A. + 
1 mM Oi(II)] 
Not found 
Mutant V 
(1 mM U.A. + 
1 mM Cu(II)] 
Not found 
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regions increased in Mill, MIV and MV as compared with MI and Mil 
(Figure 26). When we looked for secondary hair pin loop structures 
with 4-5 and 3-4 base stem-length and loop-length respectively, it was 
found that 0.5 mM uric acid and 0.5 mM Cu(II) treated mutants, ie MI 
and Mil showed 1 and 2extra secondary hair pin loop structures 
respectively, as compared to control pBS DNA (Figure 27). On the 
other hand, no similar secondary hair pin loop structure existed in 
plasmid sequences obtained on 1.0 mM uric acid and 1.0 mM Cu(II) 
treatment. These results are consistent with the general conclusion that 
with increased uric acid-Cu(II) concentration the induction of mutation 
is random. Figure 28 and 29, show the autoradiograms of spontaneous 
and induced mutants respectively. 
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FIGURE 28 : AUTORADIOGRAM OF A DENATURING 8% 
ACRYLAMIDE GEL OF SPONTANEOUSLY 
INDUCED MUTANT FLASMIDS 
Details of experiment are given in the 'Methods'. 
Ml M2 
GAT C GA T C 
I. ' 1./ 
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FIGURE 29 : AUTORADIOGRAM OF A DENATURING 8% 
ACRYLAMIDE GEL OF DNA STRAND SCISSION 
BY URIC ACID AND Cu(II) 
Ml: Mutant obtained after treatment of pBS DNA with 
0.5 mM uric acid and 0.5 mM Cu(II) 
M2: Mutant obtained after treatment of pBS DNA with 
1.0 mM uric acid and 1.0 mM Cu(II) 
Other details of the experiment are given in the 
•Methods' 
Ml M2 
GA TC GA T C 
._f 
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DISCUSSION (Part II) 
There is considerable evidence for a role of reactive oxygen species in 
mutagenesis (Imlay and Linn, 1988; Feig and Loeb, 1993). These 
species are produced by several normal metabolic processes as well as 
many mutagens, either alone or in association with transition metal ions 
(Ames, 1983; Sunderman, 1989; Kawanishi et al., 1989; Hsie et al., 
1990; Kasprzak, 1991). It was therefore of interest to study the affect 
of uric acid-Cu(II) DNA cleavage system on bacteriophage and plasmid 
replication. 
Results in this section demonstrated that: (i) the reaction of uric acid-
Cu(II) with bacteriophage lambda reduces its biological activity and 
(ii) the in vitro reaction of uric acid-Cu(II) with plasmid DNA leads to 
the generation of mutant plasmid molecules. Quenchers of active 
oxigen species are able to inhibit phage inactivation, similar to the 
inhibition of DNA cleavage reaction. It would thus appear that the 
bacteriophage inactivation is the result of strand scission in phage 
DNA. This effect is greatly enhanced when a polA mutant of E. coli 
is used as the host. However, little or no effect on phage viability is 
seen in the case of r^cA, lexk or uvrK mutants of £". coli. These results 
suggest the involvement of DNA repair polymerase but not uvrh B C 
exinuclease complex in the repair of uric acid-Cu(II) mediated DNA 
cleavage. It may be noted that flavonoid-Cu(II) mediated phage 
invactivation is also enhanced inpolA mutants (Fazal etal., 1990). The 
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results given in Table IX, would indicate that the inducible error prone 
repair pathway on induction by UV-light may also contribute to the 
repair of uric acid-Cu(II) mediated phage inactivation. However, this 
pathway is capable of operating on several types of lesions in DNA, 
whether produced by radiation or chemical agents (Walker, 1985). 
The broad distribution of mutations in the lacZ gene of plasmid 
Bluescript is indicative of random cleavage of phosphodiester bonds, 
induced by uric acid-Cu(II). The generation of oxygen radicals in the 
proximity of DNA is well established as a cause of strand scission by 
various drugs (Rahman et al., 1989; Eliot et al, 1984, Wong et al., 
1984). It is recognized by most workers that hydroxyl radical reactions 
with DNA are preceded by the production of hydroxyl radical at that 
particular site (Pryor, 1988). The results of Figure 24, would suggest 
that the binding of uric acid to DNA may not have any sequence 
specificity and thus these results are in agreement with the previous 
results of Figure 16. 
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